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SUMMARY 
 
 Two oppositely charged homopolyelectrolytes poly(2-(methacryloyloxy)ethyldimethyl-
ethylammonium bromide) (PDMAEMAQ) and poly(acrylic acid) (PAA), and amphiphilic 
diblock copolymers based on polystyrene and the ionizable block poly(acrylic acid)  were 
synthesized via Atom Transfer Radical Polymerization (ATRP). All polymers were 
characterized using 
1
H NMR and gel permeation chromatography to confirm their 
structure, molecular weight distribution and to follow the conversion. Poly(2-
(dimethylamino)ethyl methacrylate), PDMAEMA, was quaternized with ethyl bromide to 
produce PDMAEMAQ with a quaternization degree of 98%. Furthermore, poly(acrylic 
acid) segments were obtained after hydrolysis of the poly(t-butyl acrylate) block.  
 After characterization of all polymers, interpolyelectrolyte complexation in chloroform 
was carried out. A novel method was developed to transfer the insoluble polyelectrolytes 
into the organic solvent and subsequently form polymer/polymer interpolyelectrolyte 
(IPECs) in organic media. Therein, the polyelectrolyte were first reacted with oppositely 
charged low molecular weight surfactants (sodium dodecyl sulfate, SDS, and 
cetyltrimethylammonium bromide, CTAB) to form polyelectrolyte-surfactant complexes 
(PESCs). In organic solvents, analogously to the formation of IPECs in aqueous media, 
interpolyelectrolyte complexation takes place upon the direct mixing of organic solutions 
of two complementary PESCs. This process is accompanied by an entropically favorable 
release of the surfactant counterions (in the form of ion pairs or their aggregates in low 
polarity organic solvents), which were previously associated with the ionic groups of the 
polyelectrolytes in solution. These reactions are fast and lead to frozen and non-
equilibrium macromolecular co-assemblies.  
 The size and the morphologies of the IPECs in chloroform were extensively 
investigated using transmission electronic microscopy (TEM), scanning force microscopy 
(SFM), dynamic/static light scattering techniques, 
1
HMR and turbidimetric titrations, for 
two different systems: (i) homopolyelectrolyte/homopolyelectrolyte and (ii) 
homopolycation/negatively charged amphiphilic diblock copolymer. For the first system, 
the possible particle structures consist either of particles with a core formed by IPECs 
stabilized by fragments of the excess polymeric component or of vesicles (polymersomes). 
In system (ii), particles of micellar type with a core assembled from electrostatically 
coupled segments of the polymeric components can be found, surrounded by a corona built 
Summary/Zusammenfassung   5 
up either from a mixture of polystyrene blocks and excess segments of PDMAEMAQ
+
DS
-
 
chains or from a mixture of polystyrene blocks and excess parts of PA
-
CTA
+
 blocks, 
depending on which polymeric component was present in surplus during the 
interpolyelectrolyte complexation. 
 Finally, nanocapsules loaded with melatonin were fabricated using a simple 
nanoprecipitation route employing a mixture of a diblock copolymer based on poly(methyl 
methacrylate) and PDMAEMA (PMMA-b-PDMAEMA) in combination with poly( -
caprolactone), PCL. The diblock copolymers were synthesized via ATRP using PMMA-
macroinitiators for the DMAEMA polymerization. Shape and size of the nanocarriers were 
visualized by TEM, cryogenic TEM and scanning electron microscopy (SEM). Standard 
TEM for nanocapsules showed an oily core surrounded by a thin layer composed of 
PCL/PMMA-b-PDMAEMA. Cryo-TEM also indicated the presence of spherical 
nanoobjects with a diffuse polymer corona. Encapsulation efficiencies were determined 
assaying the nanoparticles by HPLC and values of ca. 30-35% are shown by the 
nanocapsules. DLS measurements further confirmed well-defined unimodal particle size 
distributions for all formulations. It was also possible to successfully incorporate platinum 
nanoparticles into the nanocarrier, as evidenced by TEM, which opens up possibilities for 
promising applications like monitoring the circulation of the drug carrier within the body. 
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ZUSAMMENFASSUNG 
  
 Zwei entgegengesetzt geladene Homopolyelectrolyte, Poly(2-(Methacryloyloxy) 
ethyldimethylammonium bromid) (PDMAEMAQ) und Polyacrylsäure (PAA), sowie 
amphiphile Diblockcopolymere auf Basis von Polystyrol und einem ionisierbaren 
Polyacrylsäure-block  wurden mittels Atom Transfer Radical Polymerisation (ATRP) 
synthetisiert. Alle Polymere wurden über 
1
H-NMR-und Gelpermeationschromatographie 
auf die Struktur und die Molekulargewichtsverteilung hin untersucht. 
Poly(2(dimethylamino)ethyl methacrylat), PDMAEMA, wurde mit Ethylbromid zu 
PDMAEMAQ bis zu einem Quaternisierungsgrad von 98% reagiert. Die 
Poly(acrylsäure)segmente wurden hingegen durch eine Hydrolyse der Poly(t-
butylacrylat)blöcke erhalten. 
 Nach der Charakterisierung aller Polymere erfolgte eine Interpolyelektrolyt- 
Komplexbildung dieser verschiedenen Polymere in Chloroform. Eine neue Methode wurde 
hierbei entwickelt um die Polyelektrolyte in das organische Lösungsmittel zu übertragen 
und eine anschliessende Polymer/Polymer Komplexbildung durchzuführen. Hierzu war es 
zuerst nötig die Polyelektrolyte mit entgegengesetzt geladenen niedermolekularen 
Tensiden (Natriumdodecylsulfat, SDS, und Cetyltrimethylammoniumbromid, CTAB) zu 
Polyelektrolyt/Tensid-Komplexen (PESCs) umzusetzen. Analog der Bildung von 
Interpolyelektrolyt-Komplexen (IPECs) in wässrigen Medien ist die anschließende 
Komplexierung der Polymere durch die direkte Mischung zweier organischer Lösungen 
mit zwei komplementären PESCs zu erreichen. Dieser Prozess wird durch eine entropisch 
günstige Freigabe der Tensid-Gegenionen (in Form von Ionenpaaren oder deren 
Aggregaten in organischen Lösemitteln geringer Polarität), die zuvor an die ionischen 
Gruppen der Polyelectrolytblöcke  in  Lösung angebunden waren, ermöglicht. Diese sehr 
schnellen Austauschreaktionen führen zu gefroren Nichtgleichgewichtsstrukturen der 
beiden aggregierenden Polymere. Die Größe und die Morphologie der IPECs in 
Chloroform wurde daher umfassend mit Hilfe der Transmissionselektronenmikroskopie 
(TEM), Rasterkraftmikroskopie (SFM), dynamischer/statischer Lichtstreuung, 
1
H-MR und 
turbidimetrischer Titration für zwei verschiedene Systeme untersucht: (i) 
Homopolyelectrolyt / Homopolyelectrolyt und (ii) Homopolykation / negativ geladenes 
Diblockcopolymer.  
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Für das erste System bestehen die möglichen Aggregatstrukturen zum einen aus Partikeln 
mit einem IPEC-Kern der durch Teile des überschüssigen Polymers stabilisiert wird, oder 
es bilden sich Vesikel (Polymersome) aus. Im System (ii) sind die Aggregate aus einem 
mizellaren IPEC Kern und einer Korona zusammengesetzt, die entsprechend der 
Stochiometrie aus einer Mischung an PS und überschüssigen PDMAEMAQ
+
DS
-
Ketten 
oder aus einem Gemisch von PS und überzähligen PAA
-
CTA
+
 Blocksegmenten besteht.  
Darüber hinaus wurden mit Melatonin geladene Nanokapseln mittels einer Nanoausfällung 
eines Diblockcopolymers auf Basis von Poly(methyl methacrylat) und PDMAEMA 
(PMMA-b-PDMAEMA) in Kombination mit Poly(ε-Caprolacton), PCL, hergestellt. Die 
Diblockcopolymere wurden per ATRP unter der Verwendung eines PMMA-
Makroinitiators für die DMAEMA Polymerisation synthetisiert. Form und Größe der 
Nanoträger ergaben sich aus TEM, cryo-TEM-und Rasterelektronenmikroskopie (REM) 
Untersuchungen. Standard TEM der Nanokapseln zeigte einen öligen Kern, der von einer 
dünnen Schicht an PCL/PMMA-b-PDMAEMA umgeben ist. Cryo-TEM offenbarte 
ebenfalls die Anwesenheit von sphärischen Nanoobjekten mit einer diffusen und 
gequollenen Polymerkorona. Die Verkapselungseffizienzen der Nanopartikel, welche 
mittels HPLC bestimmt wurden, betrugen angemessene Werte von ca. 30-35%. DLS-
Messungen bestätigten überdies unimodale Teilchengrößenverteilung für alle 
Formulierungen. Es konnten ebenfalls Platin-Nanopartikel erfolgreich in die Nanokapseln 
integriert werden, was Möglichkeiten für viel versprechende Anwendungen, wie der 
Überwachung der Zirkulation der Wirkstoffträger im Körper, eröffnet. 
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1. INTRODUCTION 
 
 This section is divided in three parts; each one intends to give a brief overview of some 
theoretical aspects related with the topic of the present work. Since the polymers used here 
were synthesized by atom transfer radical polymerization, the first part of this introduction 
deals with the most relevant basic principles of this polymerization method. The second 
part is about interpolyelectrolyte complexation, which has been reported in most of the 
cases in aqueous media and to lesser extent in low-polar organic solvents. Here, details 
about interpolyelectrolyte complexation in organic solvent are given as a proposal to obtain 
new macromolecular structures which can lead to new promising applications. And finally, 
the third part includes some fundamentals of drug delivery systems, drug encapsulation 
and some aspects that should be taken into account for the preparation of a pharmaceutical 
formulation. 
 
1.1 ATRP basics 
1.1.1 Conventional Radical Polymerization 
 
 Conventional Radical Polymerization (CRP) has played a dominant role in the industrial 
process of polymeric materials because a large variety of monomers can be polymerized 
and copolymerized under mild experimental conditions. However, CRP is difficult to 
control and very often yield polymers with ill-controlled molecular weight and broad 
polydispersity, as a consequence of irreversible biradical termination processes (coupling 
and disprorportionation reactions).
1, 2
 Recently, synthesis of well-defined polymers via so-
called controlled/”living” radical polymerization (LRP) is possible since bimolecular 
terminations are minimized and the life-time of living polymers is prolonged through the 
introduction of dormant states for the propagating species. With LRP, the final molecular 
weight can be predicted and adjusted by varying the initial ratio monomer-to-initiator, 
maintaining a narrow molecular weight distribution (1.04 <Mw/Mn<1.5).
3
 
 Traditionally, well-defined polymer architectures such as block copolymer were prepared 
via living ionic polymerization techniques. Recent advances in controlled LRP have made 
possible the synthesis of well controlled architectures which were only accessible by living 
ionic polymerization. Chain polymerizations without chain-breaking reactions are highly 
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desirable because they allow the synthesis of block copolymers by sequential addition of 
different monomers (Eq.1). When the polymerization of the monomer M1 is completed, 
the “living” reactive centers are intact because of the absence of chain-breaking reaction. 
Sequential addition of a second monomer (third and so) leads to the formation of a block 
copolymer containing M1.
4
 
 
I*
M1
I-M1n*
M2
I-M1n-M2m*   (eq.1) 
 
1.1.2 Basic Principles of LRP 
 
 Nowadays, the three most effective methods of controlling radical polymerizations, 
with future commercial promise include: Nitroxide Mediated Polymerization (NMP), 
Atom Transfer Radical Polymerization (ATRP) and Reversible Addition-Fragmentation 
chain Transfer Polymerization (RAFT). All these methods have their advantages and 
limitations. 
5-9
 But independently of the method, a LRP requires all chains to begin 
growing (reversibly via exchange process) practically at the same time and to retain their 
functionalities until the very end of the reaction. This is contrast with what occurs in 
conventional radical polymerization, where all chains terminate and initiation is never 
completed, even when all monomer is consumed. Therefore, the three basic prerequisites 
for LRP are:
10
  
1. Initiation should be completed at low monomer conversions. 
2. Relatively low MW (DP < 1000) should be targeted to avoid chain transfer. 
This requires high concentration of growing and dormant chains (e.g., > 10
-2
 
M for bulk polymerization) 
3. Concentration of propagating radicals ([P°] < 10-7 M) should be sufficiently 
low to enable growth of chains to sufficiently high MW, before they 
terminate. 
 
1.1.3 Atom Transfer Radical Polymerization 
 
 A general mechanism for ATRP is shown in Scheme 1. This method utilizes a 
reversible halogen abstraction step in which a lower oxidation state metal (Mt complexed 
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by ligand L) reacts with an alkyl halide (Pm-X) to generate a radical (Pm
.
) and a higher 
oxidation state metal complex (XMt
n+1
L, at a rate constant of activation, ka). This radical 
adds monomer to generate the polymer chain (with a rate constant of propagation, kp). The 
higher oxidation state metal can then deactivate the growing radical to generate a dormant 
chain and the lower oxidation state metal (with a rate constant of deactivation, kd). The 
molecular weight is controlled because both initiation and deactivation are fast, allowing 
for all chains to begin growing at approximately the same time while maintaining a low 
concentration of active species. 
Scheme 1. Equilibrium/Propagation Expression for ATRP 
 
PmX    +    MtL Pm
.
   +   XMt
n+1 L
ka
kd
+M
kp
kt
Pm-P1
 
 
 There are, thus, some parameters which play an important role for a successful ATRP: 
the catalyst, it includes a transition metal compound and ligands, a suitable initiator and 
appropriate polymerization conditions to lead to a living process, i.e., linear increase of the 
molecular weight with conversion and low polydispersities.  
 
Kinetics. 
 ATRP kinetics is discussed in term of copper-based catalyst. According to Scheme 1, 
using the assumption that contribution of termination becomes insignificant due to the 
persistent radical effect (PRE)
11-13
 and using a fast equilibrium approximation, which is 
necessary for observed low polydispersities, the rate law can be derived as follows: 
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 Equations 2 and 3 give more precise descriptions about how the catalyst controls the 
polymerization through the atom transfer equilibrium. In these equations, [I]0 refers to the 
initial concentration of the initiator. In eq. 2, the rate of polymerization, Rp, is first order 
with respect to the monomer, [M], and the Cu(I) concentration, [Cu
I
], in solution. A high 
concentration of Cu(II), [X-Cu
II
], slows down the rate of polymerization. Not only does the 
rate constant of propagation, kp, which is specific for each monomer, affect Rp, but also 
equilibrium constant of activation, ka and deactivation, kd. A high value for the equilibrium 
constant gives a higher rate of polymerization as well. Equation 3 illustrates how the 
polydispersity index in ATRP in the absence of significant chain termination and transfer, 
relates to the concentrations of initiator [I]0 and deactivator [X-Cu
II
], the rate constants of 
propagation (kp) and deactivation (kd), and the monomer conversion (Xp). This equation 
holds for conditions when initiator is completely consumed and degrees of polymerization 
are sufficiently high; otherwise the Poisson term should be added.
14
 The molecular weight 
distribution, Mw/Mn, decreases with conversion, Xp. A narrower molecular weight 
distribution is obtained at higher conversion, higher kd relative to kp, higher concentration 
of deactivator, and higher molecular weights, i.e., 1/[I]0. 
 
Monomer 
 Several monomers have been successfully polymerized by ATRP: styrenes,
15, 16
 
(meth)acrylates,
17, 18
 (meth)acrylamides
19, 20
 and acrylonitrile,
15, 21, 22
 which contain 
substituent that can stabilize the propagating radicals.
23, 24
 However, controlled 
polymerization of (meth)acrylic acid by ATRP presents a problem because the acid can 
poison the catalysts by coordinating to the transition metal. By this method, polymerization 
requires of protected acid monomers, further hydrolysis leads to the respective polyacid.
25, 
26
  In addition, nitrogen-containing ligands, can be protonated which interferes with the 
metal complexation ability monomers. Each monomer has its own unique atom transfer 
equilibrium constant for its active and dormant species. In the absence of any side 
reactions other than radical termination by coupling or disproportionation, a high 
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equilibrium constant will lead to a large amount of termination because of high radical 
concentration. Each monomer possesses also its own intrinsic radical propagation rate. For 
a specific monomer, the concentration of propagating radicals and the rate of the radical 
deactivation needs to be adjusted to maintain polymerization control.  
 
Initiators 
 The initiators have the main role of determining the number of growing polymer chains 
(Eq.4).
27
 If the initiation is fast and the transfer and termination negligible, then the number 
of growing chains is constant and equal to the initial initiator concentration.  
 
 
 A variety of initiators, typically alkyl halides R-X, have been used successfully in 
ATRP. To obtain well-defined polymers with narrow molecular weight distributions, the 
halide group, X, must rapidly and selectively migrate between the growing chain and the 
transition-metal complex. When X is either bromine or chlorine, the molecular weight 
control is the best. Iodine works well for acrylate polymerizations in copper-mediated 
ATRP.
28
 Fluorine is not used because the C-F bond is too strong to undergo homolytic 
cleavage. In general, any alkyl halide with activating substituents on the -carbon, such as 
aryl, carbonyl, or allyl groups, can potentially be used as ATRP initiators. Polyhalogenated 
compounds (e.g., CCl4 and CHCl3) and compounds with a weak R-X bond, such as N-X, 
S-X, and O-X, can be also be used. When the initiating moiety is attached to 
macromolecular species, macroinitiators are formed and can be used to synthesize 
block/graft copolymers. 
 The basic requirement for a good ATRP initiator is that it should have a reactivity at 
least comparable to that of the subsequently formed growing chains. This also indicates 
that not all initiators are good for all monomers. For successful initiation, the structure of 
the alkyl group (R) in the initiator should be similar to that of the dormant polymer species. 
Tertiary alkyl halides are better initiators than secondary ones, which are better than 
primary alkyl halides. These have been partially confirmed by measurements of activation 
rate constants.
29-31
 Benzyl-substituted halides are useful initiators for the polymerization of 
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styrene and its derivatives due to their structural resemblance.
32
 However, they fail in the 
polymerization of more reactive monomers in ATRP such as MMA. On the other hands, 2-
bromopropionates are good initiators for the ATRP of acrylates. 
 
Catalyst: transition metals and ligands 
 The ideal catalyst for ATRP should be highly selective for atom transfer and should not 
participate in other reactions. The catalyst is the key to ATRP since it determines the 
position of the atom transfer equilibrium and the dynamics of exchange between the 
dormant and active species. There are several prerequisites for an efficient transition metal 
catalyst. First, the metal center must have at least two readily accessible oxidation states 
separated by one electron. Second, the metal center should have reasonable affinity toward 
a halogen. Third, the coordination sphere around the metal should be expandable upon 
oxidation to selectively accommodate a (pseudo)halogen. Fourth, the ligand should 
complex the metal relatively strongly. A number of different transition metal complexes 
based on Fe,
33
 Ru,
34
 Ni,
35
 Pd
36
 have been used in ATRP. However, Cu-catalyst is the most 
successful and common one, and superior in terms of versatility and cost. 
 The main role of the ligand in ATRP is to solubilize the transition-metal salt in the 
organic media and to adjust the redox potential of the metal center for appropriate 
reactivity and dynamics for the atom transfer. 
 Nitrogen-based polydentate ligands have been shown to be very efficient ligands for 
copper catalysts in terms of controlling the polymerization reaction. A wide range of 
monomers like (meth)acrylates, styrenes, acrylonitrile, acrylamides, and vinylpyridines 
have been polymerized and copolymerized successfully with Cu-based catalysts using 
ligands with amine, pyridine, or imine substructures.
5, 31, 37-39
 These investigations revealed 
that the ligand played a crucial role in tuning the activity of the related catalyst in the 
activation and deactivation steps of the ATRP mechanism (Scheme 1). This equilibrium is 
affected by the electronic and steric effects of the ligand in the following ways. First, bulky 
ligands reduce the rate of activation, as the Cu center is harder to access for the bromine 
atom. The second, and more predominant factor, is based mainly on the electronic 
interactions of the ligand with the Cu center in the complex. For example, good π-acceptor 
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ligands efficiently stabilize the lower oxidation state of the metal center. This shifts the 
atom transfer equilibrium toward the dormant species PnX.
31
 
Solvent, Temperature and Reaction Time 
 ATRP can be carried out either in bulk, in solution, or in a heterogeneous system (e.g., 
emulsion, suspension). A solvent is sometimes necessary, especially when the obtained 
polymer is insoluble in its monomer (e.g., polyacrylonitrile). Several factors affect the 
solvent choice. Chain transfer to solvent should be minimal. In addition, interactions 
between solvent and the catalytic system should be considered to avoid catalyst poisoning 
by the solvent (e.g., carboxylic acids or phosphine in copper based ATRP)
38
 and solvent-
assisted side reactions, such as elimination of HX from polystyryl halides, which is more 
pronounced in a polar solvent,
3
 should be minimized. 
 The rate of polymerization in ATRP increases with increasing temperature due to the 
increase of both the radical propagation rate constant and the activation equilibrium 
constant. As a result of the higher activation energy for the radical propagation than for the 
radical termination, higher kp/kt ratios and better control (“livingness”) may be observed at 
higher temperatures. However, chain transfer and other side reactions become more 
pronounced at elevated temperatures.
3
 In general, the solubility of the catalyst increases at 
higher temperatures; however, catalyst decomposition may also occur with the temperature 
increase.
40, 41
 The optimal temperature depends mostly on the monomer, the catalyst, and 
the targeted molecular weight.  
 At high monomer conversions, the rate of propagation slows down considerably; 
however, the rate of any side reaction does not change significantly, as most of them are 
monomer concentration independent. Prolonged reaction times leading to nearly complete 
monomer conversion may not increase the polydispersity of the final polymer but will 
induce loss of end groups. Thus, to obtain polymers with high end-group functionality or to 
subsequently synthesize block copolymers, conversion must not exceed 95% to avoid end-
group loss. 
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1.2 Interpolyelectrolyte Complexation 
During the last decades, growing attention has been paid to the design of novel 
“intelligent” (or “smart”) polymeric architectures, which can demonstrate high response 
and sensitivity to slight variations of conditions of the surrounding medium. One of the 
possible approaches to the design of such architectures is to utilize assembly processes 
proceeding in multi-component polymer systems. In particular, one can exploit 
electrostatic interactions between oppositely charged amphiphilic block copolymers which 
is expected to result in formation of novel, yet unexplored, interpolyelectrolyte complexes 
(IPECs), and are expected to exist in the micellar form in appropriate organic solvents (or 
their mixtures).  
1.2.1 Interpolyelectrolyte Complexation in Water 
 It is well known that polyelectrolytes (PE) can form stable complexes with oppositely 
charged species because of the strong cooperative Coulombic attraction forces and the 
release of small counterions.  
 The simplest route to prepare such IPECs is a direct interaction of anionic and cationic 
amphiphilic block copolymers either in aqueous or organic solutions (Figure 1). In these 
cases, however, macromolecular micelles (common in aqueous media or reverse in organic 
media) rather than individual macromolecules (unimers) are expected interact each other 
because critical micellization concentrations of amphiphilic block copolymers are usually 
very low. In connection with this, the formation of the IPECs can be sufficiently off-
equilibrium and, therefore, hardly controlled process which may lead to so called “frozen” 
non-equilibrium structures. 
 
+ +
 
 
 
Figure 1. Interpolyelectrolyte complexation 
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 IPECs have been extensively studied for their potential and promising application in 
different fields such as medicine, biotechnology, ecology and industry. They might be used 
as membranes and ion-exchange resins
42-44
 flocculants
45-47
, layer by layer (LBL) 
assembly,
48-50
 for separation and purification of biopolymers, 
51, 52
 for micro- and 
nanoencapsulation,
53-56
 drug delivery
57, 58
 and gene delivery therapy.
59-63
  
 The formation and structure of the interpolyelectrolyte complexes depends on several 
factors such as the chemical structures of both polymers, their chain lengths, and their 
environments such as the solvent, pH, salinity, mixing ratio and temperature.
64-71
 
Complexations may lead to colloidally stable nanoparticles or to macroscopically phase 
separation in the form of flocculates or coacervates.
72, 73
 The driving force for this type of 
phase separation is the gain in entropy related to the liberation of small counterions 
originally constrained, via electrostatic attraction, in close proximity to the macroions. 
 Consequently, phase separation can be suppressed by high salt concentrations, or by 
careful selection of the molecular characteristics of the polyelectrolyte pair. Macroscopic 
phase separation of IPECs can be controlled much more effectively by means of a double-
hydrophilic block copolymer (DHBC), defined as a macromolecule consisting of a 
nonionic water-soluble chain linked to one end of a polyelectrolyte
74
 as shown in the 
Figure 2. Complexation between such a diblock copolymer and an oppositely charged 
homopolyelectrolyte leads to the formation of micelles known as polyion complex (PIC) 
micelles or block ionomer complexes (BICs)
75-77
 or vesicles.
78
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Figure 2. Formation of a micellar-type interpolyelectrolyte complex (A) Taken from [79]. 
Vesicles of PMAA49-PDMAEMA11 in water at pH = 9 (B). Taken from [78]  
 
 
1.2.2 Interpolyelectrolyte Complexation in Organic Media 
 Interpolyelectrolyte complexation in water is well documented, though in organic 
solvents the situation is rather different because, in most of the cases, direct complexation 
is impossible due to poor solubility of the polymeric components of a system.  
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 In this project a two-step approach is used to the design of novel polymeric 
architectures based on IPECs of homopolyelectrolytes and ionic amphiphilic diblock 
copolymers. The first step is a modification of the ionic (co)polymers via their interaction 
with oppositely charged surfactants in aqueous media. This enables to dissolve the 
products of the modification, i.e., complexes of ionic (co)polymers with oppositely 
charged surfactants, for example, AB‾ S+ or C+ S‾, being S‾ and S+ surfactant counterions 
(Scheme 1), in low polarity organic solvents, e.g., chloroform, toluene, etc. In the 
appropriate organic solvents (or their mixtures), such complexes are expected to be 
molecularly dispersed, that is, to exist in the state of individual polyions (unimers) 
complexed with surfactant counterions, as was observed for a number of polyelectrolyte-
surfactant complexes.  
 
Scheme 1. Ionic block copolymer-surfactant complexes AB‾ S+ and C+ S‾. 
 
B-
S+
A
C+
S-
 
 
 The second step is a complexation reaction between the molecularly dispersed 
complexes of the ionic (co)polymer with oppositely charged surfactants, AB‾ S+ and C+ S‾, 
in low polarity organic solvents (or their mixtures) (Scheme 2A). This reaction is expected 
to result in the formation of the complex copolymers A(B‾ C+) or A(B‾ (C+)n)C
+
S
-
 
(Scheme 2B) stabilized by the electrostatic interaction of their oppositely charged 
fragments. The surfactant counterions previously associated with charged groups of the 
original ionic amphiphilic diblock copolymers are thought to be released into the bulk 
solution since it is entropically favorable. 
 Due to insolubility of common IPECs in low polarity organic solvents, such complex 
copolymers are thought to undergo self-assembly to generate novel complex polymeric 
architectures (Scheme 2C). In general, the formed macromolecular architectures can be of 
various morphological types, e.g., lamellae, vesicles, spherical or cylindrical micelles. 
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Scheme 2. Expected formation of micellar IPECs in low polarity organic media.  
 
 
 Bakeev, et al.,
79, 80
 reported a first attempt to prepare IPECs by using previous 
complexation of the polyelectrolyte with oppositely charged surfactant. Stoichiometric 
polyelectrolyte-surfactant complexes (PESCs), which are insoluble in water, could be 
redissolved in low-polar organic solvents, retaining their integrity due to the strong 
electrostatic attraction between the polyion units and surfactant ionic heads in low 
permittivity media, while solubility is provided by the affinity of the hydrocarbon tails to 
and organic solvent.
79-81
 Thus far, polycations and polyanions could be transferred into 
low-polar organic solvents and an exchange reaction is expected to take place. The aim of 
Bakeev’s work was to introduce conducting doped polyaniline (PANI) into an IPEC with 
polystyrenesulfonate (PSS) anion. Later, Lokshin et al.,
82
 reported the formation of IPECs 
between PANI complexed with surfactant and DNA as well as PSS. More recently, 
Pergushov et al., reported the first reaction between polymethacrylate anions and poly(N-
ethyl-4-vinylpyridinium) cations containing surfactant ions as counterions 
(dimethyldistearylammonium cations and dodecysulfate anions, respectively) in 
chloroform yielding IPECs.
83
 Also, an investigation of complexation between DNA and a 
cationic surfactant was carried out by Sergeyev et al., demonstrating that DNA-surfactant 
complexes were soluble in chloroform and heptanes existing as individual components 
with a 1:1 stoichiometry.
84
 
 Being insoluble in various non-polar solvents, IPECs demonstrate high swelling in 
aqueous media. The micellar cores of the formed complex polymeric architectures are 
therefore expected to change their properties from a glassy state to a viscous liquid one in 
dependence on the content of water, which can be solubilized by such micellar species 
from low polarity organic solvents. This provides a unique possibility for controlled 
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reorganization of the formed polymeric architectures, especially, upon adding to their 
organic solutions some aqueous solutions of low molecular weight electrolytes, which are 
known to destroy interpolymer ionic bonds. 
 Micellar coronas can include the desired number of different non-ionic blocks, whose 
content in the formed complex polymeric architectures are determined by the chemical 
structures of the original diblock copolymers and their amounts, as well as degrees of 
polymerization of the blocks. Under appropriate conditions (if the complex cores are not 
“frozen”), the non-polar blocks differing in chemical nature are expected to demonstrate 
segregation into the different domains on the level of a single micelle, leading to a 
microphase separation in its micellar corona. In the simplest case, this process is thought 
to result in the formation of mixed, “patchy” or Janus micelles (Figure 3). 
 
 
 
Figure 3. Structures of micelles expected via interpolyelectrolyte complexation. 
 
1.3 Drug Encapsulation. Nanocontainers 
  Over the past few decades, there has been an increasing interest in developing novel 
drug delivery systems (DDS). This marked interest has several reasons: One is the fact that 
colloidal drug carriers have shown potential applications and advantages, enhancing the in 
vivo efficiency of many drugs.  Secondly, and not less important, is that, pharmaceutical 
market trend indicates nowadays that DDS are playing an important role on their sales and 
developments. The imperative necessity for searching new drug delivery methods will 
result not only in more effective and efficacious treatments against many diseases that can 
improve pharmaceutical sales and profit but also will generate new niche to provide greater 
intellectual property protection to the already existing formulations. Another reason, 
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related with the latter one, is that patent expirations are forcing to the pharmaceutical 
companies to consider product reformulations and here again, new delivery methods are 
needed to develop new formulations of “off-patent” and “soon-to-be off patent” drugs. The 
reformulation of those products has to deal with the reduction of side/toxic effects, increase 
the patient compliance and reduce health care cost.
85
 
 
1.3.1 Synthetic Polymers for Drug Delivery System (DDS) 
 Nanotechnology has impacted significantly the field of drug delivery systems (DDS). It 
provides new materials in the nanometer range which can have potential applications in 
clinical medicine and research. Even more, it offers the advantages of a more targeted drug 
delivery and a more controllable release of the therapeutic compound.
86
 
 A DDS has several functions: to protect the therapeutically active molecules against in 
vivo degradation, to prevent harmful side/toxic effects, to increase the bioavailability and 
the fraction of the drug accumulated in the targeted zone, to improve the pharmacokinetics 
and pharmacodynamics of the delivered drug.
86-88
 
 There are some requirements a polymeric material has to fulfill before being applied 
with therapeutically purposes. Two main mechanisms can be distinguished for addressing 
the desired sites for the drug release: (i) passive and (ii) active targeting.  When it is not a 
drug itself it should provide a passive function as a drug carrier and active function when 
the nanocarriers surface is functionalized with ligands that are selectively recognized by a 
receptor on the surface of the cell.
87
 Some of the following properties are expected for a 
nanocarrier:  (a) prolonged circulation in the blood; (b) ability to accumulate – specifically 
or non-specifically; (c) responsiveness to local stimuli, such as pH and/or temperature 
changes; (d) allow for an effective intracellular drug delivery and further to individual cell 
organelles, and (e) bear a contrast/reporter moiety allowing for the real-time observation of 
its accumulation inside the target. Some other properties can be added to the list, such as 
magnetic sensitivity.
89, 90
 Depending on the reticular requirements a multifunctional 
pharmaceutical nanocarrier can be constructed, having specific properties and function. In 
the Figure 4 there is a schematic representation of multifunctional nanocarriers given by 
Torchilin,
89
 explanations are given in the text of the figure.  
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Figure 4. Schematic representation of the assembly on the multifunctional pharmaceutical nanocarrier. 1 – 
Traditional ―plain‖ nanocarrier (a: drug loaded into the carrier); 2 – targeted nanocarrier  or immunocarrier 
(b: specific targeting ligand, usually a monoclonal antibody, attached to the carrier surface); 3 – magnetic 
nanocarrier (c: magnetic particles loaded into the carrier together with the drug and allowing for the carrier 
sensitivity towards the external magnetic field and its use as contrast agent for magnetic resonance imaging); 
4 – long-circulating nanocarrier (d: surface-attached protecting polymer (usually PEG) allowing for 
prolonged circulation of the nanocarrier in the blood); 5 – contrast nanocarrier for imaging purposes (e: 
heavy metal atom – 111In, 99mTc, Gd, Mn – loaded onto the nanocarrier via the carrier-incorporated chelating 
moiety for gamma- or MR imaging application); 6 – cell-penetrating nanocarrier (f: cell-penetrating peptide, 
CPP, attached to the carrier surface and allowing for the carrier enhanced uptake by the cells); 7 – DNA-
carrying nanocarrier such as lipoplex or polyplex (g: DNA complexed by the carrier via the carrier surface 
positive charged); 8 – hypothetical multifunctional nanocarrier combining the properties of the carriers No. 
1-7. Figure taken from [90]. 
 
1.3.2 Polymeric Nanoparticles for Drug Delivery 
 Synthetic polymers have been investigated as drug carriers, as a polymeric drug itself or 
in combination with small molecule drugs or biomacromolecules such as protein and 
poly(nucleic acids). It is expected that the polymer be water-soluble, non-toxic, non-
immunogenic and it needs to be safe at all stages of the drug delivery process, i.e., before 
and after drug releases, including a safe excretion. If the polymer is non-degradable (e.g. 
poly(meth)acrylates the size need to be below the renal threshold ensuring that it is not 
accumulated in the body. On the other hands, if the polymer is degradable (e.g. polyesters), 
the toxicity and/or the immune response of the degradation products have to be considered 
as well.
90
 When the polymer is a drug itself, it is a new chemical entity and has to be 
assessed as such.  
 Various types of systems have been developed to achieve controlled parental and 
peroral drug delivery or targeting to specific tissues. Colloidal drug carriers are in the 
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range between 10-600 nm, and include: liposomes, emulsions, micelles, vesicle, liquid 
crystal, micro and nanoparticles.  
 Polymeric nanoparticles refer to those nanocarriers prepared using polymers, i.e., 
nanocapsules and nanospheres. Nanoparticles have the advantage of being able to cross the 
membrane barriers, particularly in the absorptive epithelium of the small intestine.
85
  These 
drug carriers are interesting since small diameter particles have a large relative surface 
area. Particles 200 nm or greater in diameter can be cleared form the circulatory system 
faster.
85
 
 Figure 5 shows a schematic representation for the most used polymeric nanoparticles in 
drug delivery. A nanocapsule (NC) has a vesicular structure, composed of a central oily 
core surrounded by a thin polymer wall, whereas a nanosphere (NS) only consists of a 
polymer matrix. A nanoemulsion (NE), also used as nanocarrier, is prepared without 
polymer.  NC, NS, and NE are stabilized by surfactants at the interface particle/water, 
preventing particle agglomeration and/or drug leakage. Theoretically nanocapsules are 
superior to nanoemulsions because the polymer shell protects the encapsulated drug 
against the outer environment, thus, degradation is minimized.  Comparing NC versus NS, 
the former one have the advantages over the NS of their low polymer content and a high 
loading capacity for lipophilic drugs.
91
  
 These colloidal systems mentioned above can be prepared either by (i) polymerization 
of the dispersed monomers, so called interfacial polymerization, or (ii) using pre-formed 
polymers, with so called nanoprecipitation, also called interfacial deposition,
92, 93
 solvent 
evaporation,
94
 or emulsion-diffusion techniques.
95
 Since, each method offers advantages 
and disadvantages, a detailed explanation of each one is not within the scope of this 
introduction; for this reason only the two more important and most common used method 
are explained.  
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Figure 5. Schematic representation of polymeric nanoparticles used for drug delivery 
systems. 
 
 Biodegradable nanocapsules obtained by interfacial polymerization of alkyl -
cyanoacrylate monomers have been commonly used. This preparation method was 
developed by Al Khouri.
96-99
 Briefly, the cyanoacrylate monomer is polymerized together 
with the lipophilic drug. Both, monomer and drug are previously dissolved in a mixture of 
oil and lipophilic solvent (such as ethanol). The mixture contains the drug either in 
dissolved or dispersed form. It is then slowly added to a non-ionic surfactant aqueous 
solution. Due to the large excess of the lipophilic solvent, the oil phase is finely dispersed 
in the aqueous phase, and the monomer is polymerized at the oil/water interphase, and 
nanocapsules with oily core are formed.  But, the presence of residual monomers or 
oligomers or reagent from the polymerization as well as cross-reaction between the content 
of the nanocapsules, especially the drug molecules and the acrylic monomer
100
 might limit 
the potential use of the nanocapsules. This problem was overcome by Fessi by means of 
interfacial deposition of preformed polymers.
93
  
 Among the other methods to obtain nanocapsules using preformed polymer, interfacial 
deposition is nowadays one of the employed methods, because it is one of the simplest and 
most advantageous one, which allows using several biodegradable polymers, resulting in 
nanoparticles with well-defined shape and particle size. Figure 6 shows a schematic 
representation of nanoparticles preparation. By this method, nanocapsules are formed 
instantaneously by the fast diffusion of a water-miscible solvent (such as acetone) 
containing the polymer, the lipophilic drug, oil (with or without a lipophilic surfactant) into 
an aqueous phase containing a hydrophilic surfactant under moderate magnetic stirring. 
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The formation of the nanocapsule is explained by the interfacial turbulence generated 
during the fast diffusion of the water-soluble solvent in water which also provides the 
energy for oil droplet formation. Once the solvent diffusion is complete, the polymer 
aggregates around the oil droplets. The aqueous phase becomes milky with bluish 
opalescence yielding in one step nanocapsules with a spherical vesicular shape consisting 
of an oily core (where the drug is solubilized) surrounded by a thin wall of polymer 
deposited at the interphase.
101, 102
 
 
 
 
Figure 6. Schematic representation of nanocapsule preparation via interfacial 
nanoprecipitation. 
 
1.3.3 Clearance and Opsonization 
 The body defense system reacts once that a foreign particle is introduced. Since, a 
pharmaceutical nanocarrier is a foreign body an opsonization and clearance process begins 
in order to remove it prior to completion of its function. Thus, “basic” function of any 
nanocarrier is its longevity in the body.
89
 The body distributes nutrients, clears waste, and 
distributes systematically administered drugs via the vascular and lymphatic system. 
Intravenously injected particles are scavenged and cleared from the circulation by so-called 
Kupffer cells and macrophages in a process that is facilitated by surface deposition of 
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blood opsonic factor and complement proteins on the injected drug particle.
85
 The 
opsonization is the process by which bacteria (or other foreign cells) are altered by so-
called opsonins (antibodies in blood serum) to make them more susceptible to the action of 
phagocytes.  
 The clearance pharmacokinetics and behavior and tissue distribution of a drug carrier 
orally or intravenously administered are greatly influenced by its size and surface 
characteristic.
85, 103, 104
 On exposure to the blood, particles of different surface 
characteristic, size and morphology attract different arrays of opsonins as well as another 
plasma proteins, which may be taken into account for the different pattern in the rate and 
site of the particle clearance from the vasculature.
103
 Understanding how the human body 
clears particles is vital to develop a nanocarrier that target not only a relevant macrophage 
population but also to engineer a long-circulating or macrophage-evading particles.
85, 103
 
 To overcome the recognition by the mononuclear phagocyte system formulations 
“invisible” to macrophages have been developed. Coating the nanoparticles with a 
hydrophilic shell such as poly(ethyleneglycol) (PEG) suppress macrophage recognition by 
reducing protein adsorption and surface opsonization.
105, 106
 This evasion prolongs the 
circulation of the nanoparticles allowing a controlled release of the therapeutics in the 
blood.
85
 There are a vast amount of research work focused to the better understanding of 
the PEG coating to extent the particle blood circulation. Also copolymers based PEG and 
polylactide-glycol (PEG-PLAGA) have been prepared for long-circulating particles, and 
experiments in BALB/c mice have demonstrated that protective effect of PEG depends on 
the content of this block.
89, 107
 Clearance and liver accumulation patterns reveal that the 
higher content of PEG blocks, the lower the clearance and the better the protection from 
the liver uptake.
89
 Even when hydrophilicity has been considered as the main requirement, 
it is not sufficient. It has been proposed
108, 109
 that chain flexibility is also necessary to 
provide long-circulating particles. The different conformations that PEG block can adopt 
due to its transient, flexibility and rapidly changing structure, the immune system would 
have difficult in modeling an antibody around it.
110
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1.3.4 Other drug nanocarrier formulations.  
 The administration route is a very important parameter as the drug itself for the 
therapeutical success. New formulations have to enhance the circulation time in the body, 
to avoid opsonization and macrophages recognition, to cross a particular physical barrier or 
even to find an alternative for the drug delivery of the new generation protein-based 
different that the peroral one,  where drug degradation can occur during its transit along the 
gastrointestinal tract. In this sense, nanotechnology is opening new therapeutic 
opportunities for agents that cannot be used effectively as conventional drug formulations 
due to poor bioavailability or drug instability. The choice of the administration route is 
driven mainly by patient acceptability, drug properties, access to the disease location or 
effectiveness in dealing with the specific disease. The most frequently used one is the 
peroral route (oral administration), but certain numbers of drugs (as protein- and peptide-
based) do not easily cross the mucosal surfaces and biological membranes.
111
  However, it 
is still the most intensively investigated because it offers the advantages of convenience 
and cheapness of administration and potential manufacturing cost savings. On the other 
hands, parenteral routes, i.e., intravenous, intramuscular and subcutaneous, are very 
important but more invasive than peroral (and transdermal) drug administration. Nanoscale 
drug carriers have a great potential for improving the delivery of drugs through nasal and 
sublingual routes, both of which avoid first-pass metabolism; and for difficult-access 
ocular, brain and intra-articular cavities. 
 The type of the release is also important for the therapeutic success of the drug delivery. 
It can be sustained (or continues) or pulsed. Sustained release
112
 of the drug involves 
polymeric nanocarriers which release the drug at controlled rate, by diffusion out of the 
polymer or by degradation of the polymer over the time. Pulsed, highly preferred, mimics 
closely the way as the body naturally produces hormones like insulin. The drug is released 
rapidly within a short period of time, as a result of a biological or external trigger, after a 
specific lag time.
113
 It can be achieved using polymers which respond to specific stimuli, 
e.g., exposure to the light, changes in the pH or temperature.
114
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1.3.5 How is the drug released? 
 A central physical characteristic of the drug carrier systems is the drug release profile, 
which in its most fundamental form is the fraction of drug released from the disperse 
system as a function of the time after the system has been administered. This release can be 
driven by a number of processes, the most important one being:
114
 
1. The drug may diffuse cut of the carrier by diffusion in the solid matrix. This 
process is negligibly slow for macroscopic delivery systems, but can be fast for 
submicron carriers. Diffusion in solid is characterized by diffusion coefficients of   
10
-18
 to 10
-20
 m
2
/s or less, resulting in release time of the order of hours or minutes 
for a particle with a diameter in the hundred nanometer range. The carrier retains its 
structural integrity in this situation. This process can be seen as a perturbation of 
partition equilibrium, before dilution the carrier is dispersed in a small volume of 
continuous phase and the drug in partitioned between the carrier phase, [D]part, and 
the continuous phase, [D]cont, being [D] = drug concentration. On dilution the drug 
will diffuse out of the carrier until the partition equilibrium is re-established, as 
shown in the Figure 7. The rates of the forward (kf) and reverse (kr) processes may 
be functions of concentration and time, and need not to be first order. If the degree 
of dilution is large, [D]cont will be small, and the drug will partition largely into the 
aqueous phase. At infinite dilution [D]cont be zero and so the reverse rate will be 
zero. If the degree of dilution is large the drug will leave the carrier completely and 
accumulate in the continuous phase (although at zero concentration). The rate at 
which this occurs will be kf[D]cont. The theoretical situation of infinite dilute is 
known as a perfect sink (although perfect sink conditions are never attainable in 
practice). The kinetics of the release is determined only by the drug-carrier 
interaction, and is not influenced by the drug in the sink medium. 
2. The solvent may penetrate the microparticle and dissolve the drug, which then 
diffuses out in solution. The solvent may gain entry by percolation through pores, 
or hydration of the particle.  
3. The carrier may be degraded or dissolved by its surroundings, the drug being 
sufficiently immobile to diffuse from the carrier over the same timescale. In this 
case the accumulation of drug in the continuous phase follows the degradation of 
the carrier. 
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Figure 7. Diffusion equilibrium of drug between particle and continuous phase. Figure 
taken from [115]. 
 
 
Objective of this Thesis 
 The main objective of this thesis is to evaluate the behavior of amphiphilic diblock 
copolymers, commonly used in aqueous applications, to develop (i) novel 
interpolyeletrolyte complexes in a low polarity organic solvent, traditionally performed in 
aqueous media, and (ii) to formulate novel vesicular nanocarriers for drug encapsulation.  
 Due to the well known interest on polyelectrolyte complexation, the method here 
employed allowed to synthesize in organic media materials substantially water-free with 
novel nanoarchitectures that can be practically fully dried from a volatile organic solvent to 
form highly porous powders, which may be interesting, for instance, for design of novel 
separation membranes.  
 Moreover, the investigations of amphiphilic diblock copolymers in the field of 
pharmaceutical applications are mostly focused in the properties of these polymers to self-
assembly to form micelles that can be loaded with a therapeutic agent. Here, we are 
interested in using these copolymers to design a novel nanocontainer to load melatonin. To 
attempt this objective, interfacial deposition in water is employed to successfully obtain 
well nanostructured particles. 
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2. OVERVIEW OF THIS THESIS 
 
 The research presented in this work was focused on two areas: novel 
interpolyelectrolyte complexation in low polarity organic solvent and formulation of 
nanocapsules using diblock copolymers. The thesis consists of five chapters, three of them 
are articles submitted to or published in scientific journals.  
 Chapter 3 describes how interpolyelectrolyte complexation between two 
homopolyelectrolytes oppositely charged was performed in chloroform; this system served 
as a “model system”. The precursor of the homopolyelectrolytes, poly(t-butyl acrylate) 
(PtBA) and poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA) were synthesized 
via ATRP. Poly(acrylic acid) (PAA) was obtained by hydrolysis of PtBA. 
Interpolyelectrolyte complexation was carried out in a “two-step” approach. The first step 
is the preparation of polyelectrolyte-surfactant complexes (PESCs).  This was performed 
by the addition of aqueous solution of surfactant to an oppositely charged polyelectrolyte 
at constant ionic strength (0.1M NaCl). Specifically, cetyltrimethylammonium bromide 
(CTAB), a cationic surfactant, was added slowly to an aqueous solution of PAA at pH = 9 
until a precipitated of poly(cetyldrimethylammonium acrylate) (PA
-
 CTA
+
) was formed 
(ratio 1:1). Analogously, sodium dodecyl sulfate (SDS), an anionic surfactant, was added 
to an aqueous solution of PDMAEMA to form poly[2-(methacryloylethyl)dimethyl-
ethylammonium dodecyl sulfate] (PDMAEMAQ
+
 DS
-
). Both products were thoroughly 
washed to remove unreacted surfactant and low molecular weight salts and then dried until 
constant weight was reached. The second step, interpolyelectrolyte complexation, was 
performed by direct mixing in chloroform of two complementary PESCs as shown in 
2. Overview of this Thesis         47 
 
Scheme 1. Interpolyelectrolyte complexes (IPEC) are formed with the release of the 
surfactant counterions previously complexed with the polyelectrolytes.  
Scheme 1. Schematic representation for interpolyelectrolyte complexation 
 in low polarity organic media 
 
 
 
 The complexation was followed by turbidimetric titration and depending on the mixing 
ratio of PESCs (Z or Z*) soluble or insoluble complexes can be formed. The values Z and 
Z* correspond to the molar mixing ratio, i.e., Z = [PDMAEMAQ
+
DS
-
]/[PA
-
CTA
+
] and    
Z* = [PA
-
CTA
+
]/[PDMAEMAQ
+
DS
-
]. Figure 1 shows how transmission at 500 nm 
decreases as Z or Z* increases indicating the formation of insoluble IPECs. 
 
+ 
PESC
1 
PES
C2 
IPEC surfactants 
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Figure 1. Turbidimetric titration curves of a chloroform solution of PA
-
 CTA
+
 with a 
chloroform solution PDMAEMAQ
+
 DS
-
 (open circles, bottom x-axis Z = 
[PDMAEMAQ
+
 DS
-
]/[PA
-
 CTA
+
]) and a chloroform solution of PDMAEMAQ
+
 DS
-
 with 
a chloroform solution of PA
-
 CTA
+
 (solid circles, top x-axis Z* = 
[PA
-
 CTA
+
]/[PDMAEMAQ
+
 DS
-
]). 
 
 IPECs were characterized by dynamic light scattering to determine the hydrodynamic 
radii, and by TEM and SFM to visualize the morphology. Possible structures of the formed 
IPEC particles are given in the in Figure 2. Essentially, the left hand side structure 
resembles the so-called “surface excess” model to describe the structure of aggregated 
IPECs formed in aqueous media, which considers them as substantially stoichiometric 
IPECs whose particles are stabilized in aqueous media by charged fragments of the excess 
polymeric component. At the same time, vesicles (“polymersomes”) might be formed. 
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Figure 2. Schematic representation of possible structures of co-assemblies, which might 
form in the excess of PDMAEMAQ
+
 DS
-
. 
 
 Chapter 4 deals with (i) the synthesis of diblock copolymers polystyrene-block-
poly(acrylic acid) (PS-b-PAA) via ATRP, using PS as macroinitiator for t-butyl acrylate 
(tBA) protected monomer and (ii) the interpolyelectrolyte complexation in chloroform of 
these copolymers with PDMAEMAQ
+
DS
-
. To obtain the respective polyelectrolyte, the 
PtBA segemnts were hydrolyzed to poly(acrylic acid) (PAA). The copolymers were 
purified and well characterized. Figure 3 shows the GPC traces of a synthesized copolymer 
PS-b-PtBA. Traces of the macroinitiator, PS, were still present in the copolymer. To 
remove unreacted PS, the hydrolyzed copolymers were purified using a soxhlet extraction 
with toluene. The purity of copolymer was verified dissolving the copolymers in THF and 
adding a concentrated solution of NaOH to the PAA blocks to yield poly(sodium acrylate) 
(PANa). In THF, reverse micelles are formed and no traces of PS macroinitiator were 
observed.  
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Figure 3. GPC traces of the precursor PS84 (
______
), PS84-b-PtBA115 (------) and reverse 
micelles of PS84-b-PANa115 (--∙--∙--) after extraction of the residual PS. THF was used as 
the eluent. 
 
 Table 1 resumes the results from SLS and DLS. It is clearly seen that IPECs present 
much higher molecular weights than the precursors, being within Mw = 10
8
 – 109 g/mol. 
This provides clear evidence for interpolyelectrolyte complexation and suggests that the 
co-assemblies formed comprise a large number of macromolecules of the constituting 
polymeric components, and shows that complexes are stable upon dilution. The positive 
values of the second virial coefficient indicate that chloroform is a good solvent for the 
IPEC species formed. The ratio ρ = <Rg
2
>
0.5
/<Rh>z, which characterizes the shape of the 
scattering particles, ranges from 1.18 to 1.24, thus being in good agreement with the values 
for star-shaped polymers with a high number of arms. The aggregation number, Nagg, also 
gives evidence that thousands of polymeric components assemble to produce IPECs. 
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Table 1. SLS/DLS results for the IPEC particles formed in the chloroform mixtures of 
PS84-b-(PA
-
 CTA
+
)X with PDMAEMAQ
+
 DS
-
 at Z* = 0.4 (2.5-fold molar excess of the 
(DMAEMAQ
+
 DS
-
) units) 
 10
-8
 Mw, 
g/mol 
10
-3
 Nagg 
(NPS-b-A
-
 + 
NPDMAEMAQ
+
/PDMAEMA
Q
+
DS
-
) 
10
7
 A2, 
mol ml/g
2
 
<Rh>z, 
nm 
<Rg
2
>
0.5
, 
nm 
ρ 
 
PS84-b-(PA
-
 CTA
+
)115 3.05 4.6 
(2.6 + 8.9) 
5.16 80 94 1.18 
PS84-b-(PA
-
 CTA
+
)410 9.60 8.9 
(2.5 + 6.4) 
8.46 76 90 1.18 
(PA
-
 CTA
+
)415 2.29 2.2 
(0.6 + 1.6) 
1.24 76 95 1.24 
  
 The morphology of soluble IPECs was evaluated using TEM. We proposed a structure 
consisting of a compact core built up with fragments of the stoichiometric oppositely 
charged polyelectrolytes blocks, i.e., PA
-
 and PDMAEMAQ
+
. In the excess of PS84-b-(PA
-
 CTA
+
)x, the solubilizing corona should be formed by the PS blocks and those fragments of 
the PA
-
 CTA
+
 blocks, which are not involved in the interpolyelectrolyte complexation (Fig. 
4, right structure). In the excess of PDMAEMAQ
+
DS
-
, the solubilizing corona comprises 
both the PS blocks and those fragments of the PDMAEMAQ
+
DS
-
 blocks, which are not 
involved in the interpolyelectrolyte complexation (Fig. 4, left structure). 
 
 
 
Figure 4. Schematic representation of tentative, idealized structures of macromolecular co-
assemblies formed in chloroform mixtures of PS84-b-(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS. 
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 Chapter 5 presents the results of the research focused in the formulation of novel 
vesicular nanocarriers from a mixture of poly( -caprolactone) (PCL) and PMMA-b-
PDMAEMA. Two diblock copolymers with different PDMAEMA block lengths were 
synthesized via ATRP using PMMA as macroinitiator. The aim of this research was to 
formulate nanocapsules (NC) that can be loaded with the drug melatonin. Nanocapsules 
are vesicular nanoparticles composed with an oily core surrounded by a thin polymer wall. 
There are several methods to prepare nanocapsules either by polymerization of dispersed 
monomers or using pre-formed polymers. Here, a technique called interfacial deposition in 
water was used to obtain NCs. It consists in incorporating a mixture of polymers, oil, drug 
and surfactant, previously dissolved in an organic solvent like acetone, into water which 
might or might not contain a surfactant. Surfactants and/or stabilizers are used to avoid 
drug leakage and/or flocculation and sedimentation of particles. NCs are formed 
instantaneously by the fast diffusion of a water-miscible solvent with the polymer, drug 
and oil into an aqueous solution. Nevertheless, our strategy is based on the hypothesis that 
a new generation of vesicular carrier can be built directly by the mixture of both polymers 
(PCL and PMMA-b-PDMAEMA) in acetone with no need of any surfactant. PCL is a 
linear polyester widely used as polymer wall in NC formulations while PMMA-b-
PDMAEMA is an amphiphilic copolymer with potential applications chosen by its 
solubility in acetone, the ability to anchor at the polymer wall of nanocapsules and to 
interact with water at the interface. 
 One important property to evaluate is the size of the nanocarrier. Formulations here 
prepared were macroscopically homogeneous and stable. Particle size and size distribution 
were determined by means of DLS. Figure 5A shows the typical linear q
2
 dependence of 
the decay rate, , evidencing the diffusive behavior of the investigated particles. Thus, the 
Stokes-Einstein equation can be applied to determine reliable hydrodynamic radii from 
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DLS. Figure 5B indicates unimodal size distributions. Hydrodynamic radii were between 
95-180 nm (mean diameter between 180 and 360 nm) what might be suitable for oral 
administration. 
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Figure 5. Angular dependence of decay rate
 
obtained from DLS data of diluted 
nanoparticles loaded with melatonin (CNaCl = 1 mM) (  = NC1- M40D108-Mel-A;  = 
NC1- M40D471-Mel-A;  = NC2- M40D471-Mel-A). 
 
 Exhaustive morphological characterization was performed to elucidate the structure of 
the NCs. Standard TEM, cryo-TEM and SEM showed that all NC presented spherical 
shape.  Also NCs were loaded with Pt nanoparticles using hexachloroplatinum acid 
(H2PtCl6) with a posterior reduction by NaBH4. It is expected that the Pt nanoparticles 
interact with the amino group presents in PDMAEMA, however, no preferential location of 
the metallic nanoparticles were observed. The fact that NCs were built up with a polymer 
containing amino groups opens up the possibility to create a wide variety of nanoparticles 
with promising biomedical applications by complexation with metallic nanoparticles. 
 The efficiency of encapsulating melatonin was assessed by HPLC. Results showed that 
melatonin could be encapsulated inside the nanocarrier in ca. 30%. Low encapsulation 
efficiency might be attributed to the solubility of melatonin in water (0.1 mg/ml) or to the 
poor diblock ability to keep the drug encapsulated inside the oily core.  
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Abstract  
Interpolyelectrolyte complexes (IPECs) were formed in chloroform from complementary 
polyelectrolyte-surfactant complexes (PESCs), i.e., linear polyelectrolytes whose 
counterions were substituted by surfactants to dissolve them in the low polarity organic 
solvent. The interaction between such complementary PESCs was followed by 
turbidimetry, 
1
H NMR, and dynamic light scattering. The experimental results, together 
with those from transmission electron microscopy and scanning force microscopy provide 
evidence on the formation IPECs in the system. This process is apparently driven by the 
entropically favorable release of the pairs of the oppositely charged surfactant ions. If the 
mixing base-molar ratio between the complementary PESCs, Z, is below a certain 
threshold value, their chloroform mixtures are colloidally stable, containing relatively large 
aggregates. These aggregates are attributed to particles of the formed IPECs stabilized by 
the fragments of the excess polymeric component. Otherwise, the mixtures of the PESCs 
undergo phase separation (most pronounced at Z = 1) with the formation of an insoluble 
top phase (attributed to insoluble IPEC) and a clear bottom phase enriched with the 
surfactant counterions. Electron and scanning force micrographs indicate a rather broad 
size distribution of the soluble macromolecular co-assemblies with a close to spherical 
shape. 
Keywords: macromolecular co-assembly, interpolyelectrolyte complexes, polyelectrolyte-
surfactant complexes 
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3.1 Introduction 
 Oppositely charged linear polyelectrolytes interacting in a cooperative manner in 
aqueous media can form stable complexes,
72, 115-117
 often referred to as interpolyelectrolyte 
complexes (IPECs). They have found a number of important applications, e.g., in drug 
delivery,
118
 in non-viral gene transfection
119
 and in the modification of surfaces using the 
layer-by-layer technique.
120
 IPEC formation takes place due to strong Coulomb attractive 
forces, which lead to spontaneous co-assembly of the oppositely charged macromolecules, 
this process being accompanied by the concomitant, entropically favorable release of small 
counterions. The structure and the properties of IPECs are governed by several factors such 
as nature of the interacting polymeric components, their mixing ratio and concentrations, 
pH, ionic strength, etc. Depending on these parameters, either colloidally stable complex 
nanoparticles are obtained or phase separation occurs, resulting in the formation of 
complex flocculates or complex coacervates. Stoichiometric IPECs (with base-molar ratio 
of the oppositely charged polymeric components equal to unity) are neutral because 
charges of the coupled polymeric components are mutually screened. As a rule, such 
stoichiometric IPECs undergo fast secondary aggregation followed by precipitation from 
aqueous solutions. When polyelectrolytes with weak ionic groups and with a remarkable 
difference in molecular weights are complexed at non-stoichiometric mixing base-molar 
ratios, the reaction can yield water-soluble IPECs consisting of a long host polyion and 
shorter sequentially attached guest polyions of the opposite charge. Such water-soluble 
non-stoichiometric IPECs have been thoroughly investigated previously by Kabanov and 
Zezin with their co-workers.
8
 
 Only a few authors attempted to realize interpolyelectrolyte complexation in organic 
media, in particular, of low polarity. Schrage et al.
9
 described the formation of vesicles 
(often referred to as “polymersomes”) by simple mixing solutions of poly(1,2-butadiene)-
block-poly(cesium methacrylate) and polystyrene-block-poly(N-methyl-4-vinylpyridinium 
iodide) micelles in THF. Lokshin et al.
10
 reported the formation of IPECs containing 
polyaniline and either DNA or poly(styrenesulfonate) in chloroform. More recently, 
Pergushov et al.
11
 investigated interpolyelectrolyte complexation in chloroform between 
complementary polymeric components, viz., surfactant-modified linear polyions, 
poly(dioctadecyldimethylammonium methacrylate) and poly(N-ethyl-4-vinylpyridinium 
dodecylsulfate). 
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 In these latter two publications,
10,11
 a “two-step” approach was used, whereby the 
insolubility of ionic polymers in organic solvents of low polarity was successfully 
overcome by the prior substitution of small counterions of the polyelectrolytes by 
sufficiently hydrophobic surfactant counterions, viz., dioctadecyldimethylammonium 
cations and dodecylsulfate or dodecylbenzenesulfonate anions. To perform such a 
modification, aqueous solutions of oppositely charged polyelectrolyte and surfactant were 
mixed at equimolar ratio of ionic groups. This resulted in the precipitation or flocculation 
of the formed polyelectrolyte-surfactant complexes (PESCs). These PESCs are insoluble in 
water due to the compensation of ionic charges by the hydrophobic surfactant counterions. 
However, after thorough drying they are soluble in a number of low polarity organic 
solvents, such as chloroform or benzene.
12-14
 
 Analogously to the formation of IPECs in aqueous media, interpolyelectrolyte 
complexation is expected to take place upon the direct mixing organic solutions of two 
complementary PESCs. This process should be accompanied by an entropically favorable 
release of the surfactant counterions (in low polarity organic solvents in the form of ion 
pairs or their aggregates) previously associated with ionic groups of the polymeric 
components into the bulk solution. 
 Our interest in the synthesis of IPECs in organic solvents is that it opens up the 
possibility to vary solvent polarity in a rather broad range, which may lead to some novel 
nanoarchitectures. Moreover, IPECs prepared in organic media of low polarity are 
substantially free of water and can be further almost completely dried from a volatile 
organic solvent to form fine and highly porous powders, which may be afterwards used, for 
example, for design of novel separation membranes. In low polarity organic solvents, 
hydrophobic interaction can be cancelled, and thus, essentially only electrostatic 
interaction plays a role in the complexation process. These electrostatic interactions are 
naturally expected to be very strong in low permittivity media, thereby leading to non-
equilibrium (“frozen”) macromolecular co-assemblies. 
 In this work, we have synthesized IPECs in chloroform using the interaction between 
poly(cetyltrimethylammonium acrylate) (PA
-
 CTA
+
) and 
poly[(methacryloylethyl)dimethylethylammonium dodecyl sulfate] (PDMAEMAQ
+
 DS
-
). 
The latter PESC is derived from quaternized poly(2-dimethylaminoethyl methacrylate) . In 
contrast to the previous papers where the formation of only insoluble IPECs was 
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reported,
10,11
 herein we demonstrate for the first time that in the excess of one of the 
polymeric component they can be colloidally stable or even soluble in chloroform. 
 
3.2 Experimental Section 
3.2.1 Materials 
 Monomers, t-butyl acrylate (t-BuA, donated by BASF SE) and 2-dimethylaminoethyl 
methacrylate (DMAEMA, donated by BASF SE), were stirred over CaH2, distilled from 
CaH2, and degassed in high vacuum. CuBr (95%, Aldrich) and CuCl (97%, Aldrich) were 
purified by stirring overnight in acetic acid. After filtration, they were washed with 
ethanol, then with ether, and afterwards dried under vacuum. N,N,N’,N”,N”-
pentamethyldiethylenetriamine (PMDETA, 99%, Aldrich) and ethyl-2-bromo-2-
isobutyrate (EBIB, 98%, Aldrich) were distilled and degassed. 1,1,4,7,10,10-
Hexamethyltriethylenetetramine (HMTETA, 97%, Aldrich), p-toluenesulfonyl chloride (p-
TsCl, 99%, Aldrich), trifluoroacetic acid (CF3COOH, 99%, Aldrich), ethyl bromide 
(Aldrich, 99%), sodium dodecylsulfate (SDS) and cetyltrimethylammonium bromide, 
(CTAB) (both 99%, Aldrich) and chloroform (anhydrous, 99%, Aldrich) were 
commercially obtained and used without further purification.  
3.2.2 Polymer Synthesis 
 Polymers were synthesized through atom transfer radical polymerization (ATRP) of 
DMAEMA and t-BuA. All polymerizations were carried out inside a glovebox under 
nitrogen atmosphere. The prepared polymers, poly(2-dimethylaminoethyl methacrylate) 
(PDMAEMA) and poly(tert-butylacrylate) (PtBA), were characterized by 
1
H NMR and 
GPC to determine their structures as well as molecular weight distributions. Table 1 
summarizes the experimental data for both polyelectrolyte precursors. GPC traces (not 
shown) indicated a unimodal molecular weight distribution in each case. Hydrolysis of 
PtBA performed under mild conditions with CF3COOH was verified by means of 
1
H NMR 
through the disappearance of proton signals corresponding to the t-butyl groups. 
Quaternization of PDMAEMA with ethyl bromide was verified by 
1
H NMR and quantified 
by elemental analysis. 
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Table 1. Experimental conditions and results of the synthesis of polyelectrolyte precursors. 
Polymer [M]0:[I]0:[Cu]:[L] T,°C 10
3
 Mn,GPC  
(PDI) 
DPn,GPC Conversion 
(%) 
PDMAEMA 520:1:1:1 90 61.0 (1.43)
a
 390
a
 32
c
 
PtBA 380:1:1:1 60 53.0 (1.08)
b
 415
b
 83
d
 
a)
 Determined by GPC in THF with tetrabutylammonium bromide using PS calibration. 
b)
 
Determined by GPC in THF using PtBA calibration. 
c)
 Determined by gas chromatography. 
d)
 
Determined by 
1
H NMR. 
 
 3.2.2.1 Synthesis and quaternization of poly(2-dimethylaminoethyl methacrylate) 
(PDMAEMA).  
 The polymerization of DMAEMA was carried out according to the procedure reported 
by Gan et al.
15
 DMAEMA monomer (20 g, 0.127 mol) was added to a round bottom flask 
containing CuCl (0.0252 g, 0.254 mmol), HMTETA (0.0586 g, 0.254 mmol), and anisole 
(10.0 g, 50 wt%). The solution was stirred until the Cu complex was formed, which was 
easily observed by the dissolution of the copper and the change of the solution from 
colorless to light yellow-green. After the Cu-ligand complex formation, p-TsCl (0.0485 g, 
0.254 mmol) was added to the mixture and the initial sample was taken. The flask was 
sealed with a plastic cap and reaction solution was immersed for 180 min into an oil bath 
thermostated at 90°C. The final conversion was determined by gas chromatography. 
PDMAEMA (2g, 0.012 mol) was exhaustively quaternized with a 10-fold molar excess of 
ethylbromide in methanol at room temperature. The degree of quaternization, as 
determined by elemental analysis of bromine, was equal to ca 90%. 
 3.2.2.2 Synthesis of poly(acrylic acid) (PAA).  
 CuBr (0.0589 g, 0.411 mmol), PMDETA (0.0714 g, 0.411 mmol), t-BuA (20g, 0.156 
mol), and ethyl acetate (5g, 25 wt%) were added into a round bottom flask and the mixture 
was stirred until complete dissolution of the Cu complex. When the Cu catalyst was 
formed, the initiator, EBIB (0.0802 g, 0.411 mmol), was added. The flask was placed for 
22.5 h into an oil bath thermostated at 60°C. The conversion of the double bonds was 
confirmed by 
1
H-NMR. The hydrolysis of t-butyl groups was carried out via dissolving 
PtBA in CH2Cl2 and adding a 5-fold molar excess of CF3COOH. The mixture was stirred 
at room temperature for 24 h while PAA gradually precipitated in CH2Cl2. The solvent and 
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CF3COOH were afterwards removed by rotating evaporation followed by freeze-drying. 
The polymer was finally dried under vacuum at 40°C overnight. 
3.2.3 Preparation of Polyelectrolyte-Surfactant Complexes (PESCs). 
 PESCs soluble in chloroform were successfully synthesized with a yield of more than 
90% following a procedure similar to that reported by Pergushov et. al.
11
 Specifically, the 
aqueous solution of the surfactant was added to an aqueous solution of the oppositely 
charged polyelectrolyte at constant ionic strength (0.1M NaCl). PDMAEMAQ, (5mM) was 
dissolved in Millipore water, and SDS (0.01M) was added dropwise under continuous 
stirring. At the 1 : 1 ratio between concentrations of ionic groups of PDMAEMAQ and 
SDS, the formed PESC precipitated and a ca. 5% molar excess of surfactant was added. 
The PESC, referred to as PDMAEMAQ
+
 DS
-
, was filtered under vacuum using a funnel 
with a glass frit and rinsed with distilled water to remove unreacted surfactant and low 
molecular weight salt. Afterwards, the PESC was allowed to dry first in an oven at 40°C 
for 4 h, and then under vacuum at room temperature for 10 days. Complexation between 
the sodium salt of PAA, PANa (5mM), and CTAB was performed in a similar manner in 
0.01M TRIS HCl buffer (pH 9) to ensure a complete ionization of acrylic acid units. The 
obtained PESC is referred to as PA
-
 CTA
+
. The degree of substitution of the small 
counterions by the corresponding surfactant-counterions was determined by elemental 
analysis of nitrogen for PA
-
 CTA
+
 as 87%. For PDMAEMAQ
+
 DS
-
, elemental analysis of 
nitrogen and sulfur resulted a degree of substitution of 98 %. 
3.2.4 Characterization 
 1
H NMR spectra were recorded with a Bruker AC-250 spectrometer at room 
temperature using deuterated chloroform. Molecular weight distributions were measured 
by gel permeation chromatography (GPC) with THF as the eluent. In the case of 
PDMAEMA, GPC analysis was performed using THF with tetrabutylammonium bromide 
as the eluent. The instrument was operated at a flow rate of 1.0 mL/min at room 
temperature. A column set, 5  SDV gel, 10
2
-10
5
 Å, 30 cm each (PSS, Germany), was used 
together with a differential refractometer and an UV-detector operated at the wavelength of 
254 nm. Polystyrene standards (PSS, Germany) were used for the calibration of the column 
set. Turbidimetric titrations were carried out with a Perkin-Elmer Lambda 15 UV/vis-
spectrophotometer at the wavelength of 500 nm. At this wavelength, polymers do not 
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absorb light; therefore, optical density values are attributed only to the light scattering. 
Particle size distributions were determined by means of dynamic light scattering 
measurements (DLS) with an ALV DLS/SLS SP 5022F equipment and a He-Ne laser 
( =632.8 nm) as a light source. Prior to measurements, samples were filtered using PTFE 
filter (Millipore) with a pore size of 1 µm. The CONTIN program was employed to 
analyze the autocorrelation functions measured at the scattering angle of 90º. Transmission 
electron microscopy (TEM) images were taken using a Zeiss EM 922 transmission electron 
microscope operated at 200 kV. Typically, a 5- L droplet of IPEC solution in chloroform 
was deposited onto the copper TEM grid coated with a carbon film. Scanning force 
microscopy (SFM) measurements were performed using a Digital Instrument Dimension 
3100 microscope operated in Tapping Mode. Samples were prepared by a dip-coating from 
dilute solutions of IPECs in chloroform onto freshly cleaved mica surface. 
 
3.3 Results and Discussion 
3.3.1 Interpolyelectrolyte Complexation in Chloroform  
 After being thoroughly dried, the polyelectrolyte-surfactant complexes (PESCs) PA
-
 CTA
+
 and PDMAEMAQ
+
 DS
-
, prepared as described in Experimental Section, were 
dissolved in anhydrous chloroform. Figure 1 shows that the chloroform solutions of these 
PESCs are transparent even at relatively high concentrations (ca. 1 wt %). When both 
transparent chloroform solutions containing complementary PESCs are mixed at the base-
molar ratio Z = [PDMAEMAQ
+
 DS
-
]/[PA
-
 CTA
+
] or Z* = [PA
-
 CTA
+
]/[PDMAEMAQ
+
 DS
-
] (where the molar concentrations of monomer units 
complexed with surfactant ions are given in the brackets), equal to unity (Z = Z* = 1), a 
distinct phase separation occurs. As is clearly seen from Figure 1, insoluble particles float 
on a transparent bottom phase. This finding strongly suggests that the two complementary 
PESCs interact in chloroform, generating an insoluble IPEC of PDMAEMAQ
+
 and PA
-
. 
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Figure 1. Solutions of PESCs PA
-
 CTA
+
 and PDMAEMAQ
+
 DS
-
 in chloroform (1 wt %) 
and their mixture at [PA
-
 CTA
+
] = [PDMAEMAQ
+
 DS
-
] ca. 5 min after mixing. 
 
 The interpolyelectrolyte complexation in chloroform was followed by turbidimetric 
titration. In Figure 2, the resulting curves are shown for the experiments carried out using 
the PA
-
 CTA
+
 chloroform solution either as the titrand or the titrant. First, a chloroform 
solution of PA
-
 CTA
+
 ([PA
-
 CTA
+
] = 4.29 mM) was used as the titrand and a 10 times 
more concentrated chloroform solution of PDMAEMAQ
+
 DS
-
 ([PDMAEMAQ
+
 DS
-
] = 
42.9 mM) was added as the titrant (open circles). A decrease of the transmittance was 
already observed on addition of very low amounts of the titrant solution. For the used 
concentrations of the PESCs, opalescent but colloidally stable mixtures were obtained only 
at Z  0.2. On the other hand, when PDMAEMAQ
+
 DS
-
 ([PDMAEMAQ
+
 DS
-
] = 4.29 
mM) was titrated with a 10 times more concentrated chloroform solution of PA
-
 CTA
+
 
([PA
-
 CTA
+
] = 42.9 mM), the behavior was different from that observed before (solid 
circles). Homogeneous mixtures demonstrating virtually no opalescence are formed at Z* 
 0.6. Further addition of PA
-
 CTA
+
 resulted in a gradual pronounced decrease of 
transmittance due to the formation of insoluble particles and did not lead to the re-
dissolution of the aggregates even at Z* = 1.8, that is, at the more than the 1.5-fold excess 
of PA
-
 CTA
+
. This finding can be explained by the formation of substantially “frozen” co-
assemblies in this organic media of low permittivity (  = 4.8). 
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Figure 2. Turbidimetric titration curves of a chloroform solution of PA
-
 CTA
+
 with a 
chloroform solution PDMAEMAQ
+
 DS
-
 (open circles, bottom x-axis  Z = 
[PDMAEMAQ
+
 DS
-
]/[PA
-
 CTA
+
]) and a chloroform solution of PDMAEMAQ
+
 DS
-
 with 
a chloroform solution of PA
-
 CTA
+
 (solid circles, top x-axis Z*=[PA
-
 CTA
+
]/[PDMAEMAQ
+
 DS
-
]). 
 
 One may attribute the formation of insoluble IPECs already at rather low values of Z 
(when PA
-
 CTA
+
 acts as the titrand) to a rather poor solubilizing power of the PA
-
 CTA
+
 
fragments in chloroform. Indeed, not all counterions of PANa are substituted by surfactant 
counterions (see Experimental Section) and therefore a certain fraction of A
-
Na
+
 groups is 
not balanced by CTA
+
 counterions. This would apparently worsen the solubilizing power 
of PA
-
 CTA
+
 and may even result in a clustering of such groups in chloroform. Bakeev et 
al.
13,14
 reported that aggregation (intermolecular and even intermolecular) of salt groups of 
non-stoichiometric PESCs with a partial substitution of small counterions by surfactant 
counterions, may occur in solvents of low polarity. 
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Scheme 1. Schematic representation for interpolyelectrolyte complexation 
 in low polarity organic media. 
 
 
 
 
 
 
 It is reasonable to assume that driving force of interpolyelectrolyte complexation in low 
polarity organic media is the release of surfactant counterions previously associated with 
the polyelectrolytes. This process is shown in the Scheme 1, the surfactant counterions 
being released most probably as ion pairs or their aggregates. To verify the release of the 
surfactant counterions into the bulk solution due to interpolyelectrolyte complexation, the 
deuterated chloroform solutions of the PESCs were mixed at [PA
-
 CTA
+
] = 
[PDMAEMAQ
+
 DS
-
] (Z = Z* = 1) and after macroscopic phase separation the resulting 
transparent bottom phase was taken out to be analyzed by 
1
H NMR (Figure 3C). Figures 
3A and 3B show the 
1
H NMR spectra of the used surfactants and the corresponding proton 
assignments. Due to poor solubility of SDS in chloroform, its 
1
H NMR spectrum was 
measured in deuterated water, though chemical shifts are expected to be different from 
those one would obtain in deuterated chloroform. The 
1
H NMR spectra for the original 
PESCs presented in Figs 3D and 3E were also recorded as reference. 
 The analysis of the 
1
H NMR spectra corresponding to the PESCs (Figs 3D and 3E) 
indicates that the intensities of the proton signals of the polyelectrolyte components 
considerably decrease after the complexation with the surfactants (spectra not shown). This 
may be attributed to the fact that upon incorporation of the surfactant counterions the 
contribution of the proton signals from the polyelectrolyte components decreases, resulting 
in their lower intensity. Also, the methylene protons from the surfactants and 
polyelectrolyte components overlap and clear assignments could not be performed. From 
the 
1
H NMR spectrum of the bottom phase after separation of the IPEC (Figure 3C) it can 
be seen that the assignments of the proton signals correspond rather well to those of the 
+ 
PESC1 PESC2 IPEC surfactants 
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surfactants. As the signals from protons of the polyelectrolyte components are of very low 
intensity even for the original PESCs, we cannot draw unambiguous inference about their 
presence or the absence in the bottom phase. At the same time, however, it appears obvious 
that the bottom phase is rich with surfactant counterions. 
 
 
Figure 3. 
1
H NMR spectra of (A) the solution of SDS in D2O, (B) the solution of CTAB in 
CDCl3, (C) the bottom phase formed upon mixing solutions of PA
-
 CTA
+
 and 
PDMAEMAQ
+
 DS
-
 in CDCl3 at [PA
-
 CTA
+
] = [PDMAEMAQ
+
 DS
-
], (D) the solution of 
PA
-
 CTA
+
 in CDCl3, (E) the solution of PDMAEMAQ
+
 DS
-
 in CDCl3. 
 
3.3.2 Characterization of IPECs 
 Dynamic light scattering (DLS) measurements were performed for chloroform mixtures 
of PA
-
 CTA
+
 and PDMAEMAQ
+
 DS
-
 at Z = 0.2 (5-fold excess of PA
-
 CTA
+
) or Z* = 0.2 
(5-fold excess of PDMAEMAQ
+
 DS
-
), respectively. As seen from Figure 4, the resulting 
CONTIN plots for such mixtures apparently demonstrate the co-existence of two 
populations of the scattering particles in both cases, with larger species (<Rh,app>z  70 nm) 
giving a dominant contribution to the intensity of the scattered light. For comparison, DLS 
measurements were also performed for the chloroform solutions of the original PESCs at 
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the same concentrations as the concentration of the excess polymeric component in the 
chloroform mixtures of PA
-
 CTA
+
 and PDMAEMAQ
+
 DS
-
 (results are not shown). In the 
latter case, the obtained autocorrelation functions were very noisy, the scattering intensities 
were rather low, and the scattering particles demonstrated a very broad size distribution 
with the <Rh,app>z  10  20 nm. The fact that the pattern of the autocorrelation functions 
and the scattering behavior of the individual PESCs in chloroform differ substantially from 
that observed for their chloroform mixtures strongly suggests that the detected large 
scattering particles can be considered as co-assemblies formed due to interaction between 
PA
-
 CTA
+
 and PDMAEMAQ
+
 DS
-
. The small scattering particles with <Rh,app>z  8  10 
nm are most likely either precursors of the large co-assemblies resulting from their 
secondary aggregation or single PESC unimers not involved in the interpolyelectrolyte 
complexation. 
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Figure 4. Intensity-weighted distribution of apparent hydrodynamic radii of particles 
formed in chloroform mixtures of PA
-
 CTA
+
 and PDMAEMAQ
+
 DS
-
 at 5-fold excess of 
PA
-
 CTA
+
 (Z = 0.2, open circles) and at 5-fold excess of PDMAEMAQ
+
 DS
-
 (Z* = 0.2, 
solid circles). Total base-molar concentration of the excess polymeric component was 
equal to 2.6 g/L. 
 
 We anticipated that the interaction between the PESCs in the excess of one of the 
polymeric components would result in macromolecular co-assemblies of micellar type with 
a rather compact core assembled from the oppositely charged fragments of PA
-
 and 
PDMAEMAQ
+
, which substantially represents a stoichiometric IPEC, surrounded by a 
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swollen corona built up from fragments (loops/tails) of the excess polymeric component, 
providing solubility for the whole complex species in low polarity organic media. Figure 5 
shows transmission electron microscopy (TEM) images of IPECs formed in the excess of 
PDMAEMAQ
+
 DS
-
 at Z* = 0.2. In general, the observed particles demonstrate a spherical 
shape with a rather broad particle size distribution. The number-average radius, <R>n, (and 
its standard deviation) of the IPEC particles obtained from the TEM images presented in 
Figure 5 was evaluated as <R>n = 60 ± 26 nm, which compares well to the z-average 
hydrodynamic radius of the corresponding large complex aggregates measured by DLS, 
<Rh,app>z  70 nm (Figure 4), taking into account the collapsed state of the aggregates in 
TEM and the different averages. At the same time, micrograph 5A apparently indicates a 
rather complex structure of the generated macromolecular co-assemblies. Indeed, the dark 
ring and the dark circle with a bright ring of the thickness ca. 40  50 nm in between 
clearly observed in the enlargement of some of the objects given in the TEM images 
(Figure 5), pointing to a vesicular structure. Possible structures of the formed IPEC 
particles are given in the bottom chart in Figure 5. Essentially, the left hand side structure 
resembles the so-called “surface excess” model proposed earlier16,17 to describe the 
structure of aggregated IPECs formed in aqueous media, which considers them as 
substantially stoichiometric IPECs whose particles are stabilized in aqueous media by 
charged fragments of the excess polymeric component. At the same time, vesicles 
(“polymersomes”) were observed earlier by Schrage et al.9 upon the interaction of micelles 
of poly(1,2-butadiene)-block-poly(cesium methacrylate) and polystyrene-block-
poly(1-methyl-4-vinylpyridinium iodide) in THF. 
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Figure 5. TEM images of the IPEC particles formed in the chloroform mixture of PA
-
 CTA
+
 and PDMAEMAQ
+
 DS
-
 at Z* = 0.2 (top). Schematic representation of possible 
structures of co-assemblies, which might form in the excess of PDMAEMAQ
+
 DS
-
 
(bottom). 
 
 Tapping mode scanning force microscopy (SFM) was used to image the same IPEC that 
was measured by TEM. Figure 6 shows the obtained phase and height images. As was 
observed in the TEM images (Figure 5), the observable objects show a close to spherical 
shape and rather high polydispersity with a number-average radius from 80 up to 160 nm. 
Taking into account the convolution of the signal by the finite size of the of the SFM 
cantilever tip (typically around 20 nm), these values are in good agreement with <Rh,app> 
and <RTEM> (Figs 4 and 5). The observed high polydispersity can most probably be 
A B 
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attributed to the formation of so-called “frozen” structures upon mixing chloroform 
solutions of both PESCs which do not re-arrange once they are formed. 
 
Figure 6. SFM images of IPEC particles formed in the chloroform mixture of PA
-
 CTA
+
 
and PDMAEMAQ
+
 DS
-
in the excess of PDMAEMAQ
+
 DS
-
 at Z*=0.2. Dip coating onto 
mica. Left: height image, right: phase image. 
 
3.4 Conclusions 
 Our experimental results provide evidence that interpolyelectrolyte complexation in 
chloroform, a low polarity organic solvent, can be realized if low molecular weight 
counterions of the complementary polyelectrolytes are substituted by sufficiently 
hydrophobic surfactant counterions. This process results in the formation of aggregated 
complex particles. Analogously to aqueous media where the driving force for 
interpolyelectrolyte complexation is the release of low molecular weight counterions into 
bulk solution, such a process in organic media of low polarity is most probably driven by a 
concomitant release of surfactant counterions (apparently, as pairs of oppositely charged 
surfactant ions). TEM and SFM show close to spherical particles with a rather broad 
particle size distribution, most likely due to frozen structures. 
 
 
 
3. Interpolyelectrolyte Complexation of Homopolyelectrolytes     72 
 
Acknowledgements   
 This work was supported by the EU Marie Curie Research and Training Network 
POLYAMPHI, (project no. EU MCRTN-CT-2003-505027). D.V.P. thanks the Deutsche 
Forschungsgemeinschaft for the financial support of his research stays at Universität 
Bayreuth. 
 
References 
(1)    Smid, J.; Fish, D., In Encyclopedia of Polymer Science and Engineering; Mark, H.F., 
Bikales, N.M., Overberger, C.G., Menges G., Eds.; Wiley: New York, 1988, Vol. 11, 
pp. 720-739. 
(2)  Philipp, B.; Dautzenberg, H.; Linow, K.-J.; Kötz, J.; Dawydoff, W., Progr. Polym. 
Sci., 1989, 14, 91-172. 
(3)    Kabanov, V.A., In Macromolecular Complexes in Chemistry and Biology; Dubin, P., 
Bock, J., Davies, R.M., Schulz, D.N., Thies C. Eds.; Springer: Berlin, 1994, pp. 151-
174.  
(4)    Thünemann, A.F.; Müller, M.; Dautzenberg, H.; Joanny, J.F.; Löwen, H., Adv. 
Polym. Sci., 2004, 166, 113-171. 
(5)  Kabanov, A.V.; Kabanov, V.A., Adv. Drug Delivery Rev., 1998, 30, 49-60. 
(6)  Wong, S.Y.; Pelet, J.M.; Putnam, D., Progr. Polym. Sci., 2007, 32, 799-837  
(7)     Decher, G., Science, 1997, 277, 1232-1237. 
(8)     Kabanov, V.A.; Zezin, A.B., Pure Appl. Chem., 1984, 56, 343-354. 
(9)     Schrage, S.; Sigel, R.; Schlaad, H., Macromolecules, 2003, 36, 1417-1420. 
(10) Lokshin, N.A.; Sergeyev, V.G.; Zezin, A.B.; Golubev, V.B.; Levon, K.; Kabanov, 
V.A., Langmuir, 2003, 19, 7564-7568. 
(11) Pergushov, D.V.; Remizova, E.V.; Zezin, A.B.; Kabanov, V.A., Doklady Phys. 
Chem., 2006, 406, Part 2, 38-42. 
(12) Bakeev, K.N.; Shu, Y.M.; Zezin, A.B.; Kabanov, V.A., Doklady Akademii Nauk (in 
Russian) 1993, 332, 450-453. 
(13) Bakeev, K.N.; Shu, Y.M.; MacKnight, W.J.; Zezin, A.B.; Kabanov, V.A., 
Macromolecules, 1994, 27, 300-302. 
(14) Bakeev, K.N.; Shu, Y.M.; Zezin, A.B.; Kabanov, V.A.; Lezov, A.V.; Mel'nikov, 
A.B.; Kolomiets, I.P.; Rjumtsev, E.I.; MacKnight, W.J., Macromolecules, 1996, 29, 
1320-1325. 
(15) Gan, L.-H.; Ravi, P.; Mao, B.W.; Tam, K.-C., J. Polym. Sci. A: Polym. Chem., 2003, 
41, 2688-2695. 
(16) Pergushov, D.V.; Buchhammer, H.-M.; Lunkwitz, K., Colloid Polym. Sci., 1999, 
277, 101-107. 
3. Interpolyelectrolyte Complexation of Homopolyelectrolytes     73 
 
(17) Chen, J.; Heitmann, J.A.; Hubbe, M.A., Colloids Surf. A: Physicochem. Eng. 
Aspects, 2003, 223, 215-230.  
  
4. INTERPOLYELECTROLYTE COMPLEXES OF DIBLOCK  
COPOLYMERS VIA INTERACTION OF COMPLEMENTARY 
POLYELECTROLYTE-SURFACTANT COMPLEXES IN 
CHLOROFORM 
Evis K. Penott-Chang
a,†
, Markus Ruppel
a,‡
, Dmitry V. Pergushov
b
, Alexander B. Zezin
b
,  
Axel H. E. Müller
a,
* 
a
Makromolekulare Chemie II and Bayreuther Zentrum für Kolloide und Grenzflächen, 
Universität Bayreuth, D-95440 Bayreuth, Germany 
b
Department of Polymer Science, School of Chemistry, Moscow State University, 
Vorob’evy Gory, 119991, Moscow, Russia. 
 
* Corresponding Author and Mailing Address: 
Prof. Dr. Axel Müller: 
Lehrstuhl für Makromolekulare Chemie II. 
Universität Bayreuth Universitätsstr. 30. 
Gebäude NW II D-95447 Bayreuth 
Telephone: +49 921 553399 
Fax: +49 921 553393 
Email: axel.mueller@uni-bayreuth.de 
 
 
 
Accepted in Polymer, July 2011 
DOI: 10.1016/j.polymer.2011.07.017 
 
4. IPECs of Diblock Copolymers 75 
 
Abstract 
 
 We have studied the interpolyelectrolyte complexation in chloroform between 
polystyrene-block-poly(cetyltrimethylammonium acrylate), (PA- CTA+), and poly(2-
(methacryloyloxy)ethyldimethylethylammonium dodecyl sulfate) (quaternized poly(2-
(dimethylamino)ethyl methacrylate) complexed with sodium dodecyl sulfate), 
(PDMAEMAQ+ DS-). Turbidimetry, dynamic/static light scattering, and transmission 
electron microscopy show the formation of large aggregated interpolyelectrolyte complex 
species, which are colloidally stable in chloroform or even chloroform-soluble if the 
certain conditions are met. We suggest such co-assemblies to be micellar species with a 
core assembled from electrostatically coupled fragments of the polymeric components. The 
corona is built up either from a mixture of polystyrene blocks and excessive fragments of 
(PDMAEMAQ+ DS-) chains or from a mixture of polystyrene blocks and excessive 
fragments of (PA- CTA+) blocks, depending on which polymeric component was taken in 
excess for the interpolyelectrolyte complexation. However, their real structures may 
deviate from such idealized consideration because of the non-equilibrium character of 
interpolyelectrolyte complexation in organic media of low polarity. 
 
Keywords: interpolyelectrolyte complexes, macromolecular co-assembly, polymer-
surfactant complexes, interpolyelectrolyte complexation in organic solvent. 
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4.1 Introduction 
 Interpolyelectrolyte complexation taking place upon simple mixing aqueous solutions of 
the oppositely charged polymeric components represents an easy and attractive way to 
design macromolecular co-assemblies, so-called interpolyelectrolyte complexes (IPECs) 
[1-5], which have remarkable and often even unique properties. The use of ionic 
amphiphilic diblock copolymers, which are well known to undergo self-assembly in water 
[6], thereby generating micelles, offers possibilities to obtain novel IPECs of micellar type 
with peculiar core-shell-corona (also referred to as “onion-like”) structure [7]. Previously, 
we thoroughly investigated the interaction of star-like micelles generated in aqueous 
solutions of ionic amphiphilic diblock copolymers, viz., polyisobutylene-block-
poly(sodium methacrylate), with a strong cationic polyelectrolyte, viz., exhaustively 
quaternized poly(4-vinylpyridine), and demonstrated the formation of such micellar IPECs 
[7-11]. 
 At the same time, interesting complex macromolecular architectures of 
micellar/vesicular type can result from interpolyelectrolyte complexation performed in 
organic media, in particular in organic media of low polarity. Schrage et al. [12] studied 
the interaction between polybutadiene-block-poly(cesium methacrylate) and polystyrene-
block-poly(N-methyl-4-vinylpyridinium iodide) micelles in THF and demonstrated the 
formation of complex vesicles (often referred to as “polymersomes”), where the vesicle 
wall consisted of the IPEC assembled from two oppositely charged polyelectrolyte blocks. 
Recently [13], we have successfully achieved to match poly(cetyltrimethylammonium 
acrylate) (PA
-
 CTA
+
) and poly(2-(methacryloyloxy)ethyldimethylethylammonium dodecyl 
sulfate) (derived from poly(2-(dimethylamino)ethyl methacrylate) via its quaternization 
with ethyl bromide followed by complexation of the quaternized product with sodium 
dodecyl sulfate) (PDMAEMAQ
+
 DS
-
) and demonstrated for the first time that colloidally 
stable in chloroform or even chloroform-soluble macromolecular co-assemblies can result 
from this process. 
 To realize interpolyelectrolyte complexation in organic media of low polarity, the 
insolubility of the ionic polymers in chloroform was advantageously overcome by their 
prior modification by sufficiently hydrophobic surfactants, leading to efficient substitution 
of small counterions of those polymers by surfactant counterions. Provided that 
considerable fraction of the small counterions are substituted by the hydrophobic surfactant 
counterions, such polyelectrolyte-surfactant complexes (PESCs) can be dissolved in some 
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low-polar organic solvents [14-17], among which chloroform appears to be the best. 
Solubility of those PESCs is obviously granted by strong affinity of hydrocarbon tails of 
the surfactant counterions to the organic solvent. 
 Further direct mixing of organic solutions of two complementary PESCs leads to the 
formation of IPECs, which can be either insoluble [13,18] or soluble [13], depending on 
the conditions used. We assume [13,18] that interpolyelectrolyte complexation in low-
permittivity organic media is predominantly driven by an entropically favorable release of 
surfactant counterions previously associated with ionic groups on the polymeric 
components into the bulk solution (in the form of ion pairs or their aggregates). As the 
electrostatic interaction in organic solvents of low polarity is naturally expected to be very 
strong, essentially non-equilibrium (“frozen”) IPECs, apparently result from the interaction 
between such two complementary PESCs. Our recent results [8] indicate that the 
interaction between PA
-
 CTA
+
 and PDMAEMAQ
+
 DS
-
 in chloroform leads to the 
formation of relatively large (aggregated) macromolecular co-assemblies, which appear to 
be “frozen” vesicles or micelles. 
 Apart from a fundamental aspect, our interest in the synthesis of IPECs in organic 
solvents of low polarity is based on the fact that they can be prepared substantially free of 
water and further almost completely dried from a volatile organic solvent to form fine and 
highly porous powders, which, for example, are suitable as modifiers and fillers of 
traditional polymer materials. Additionally, chloroform-soluble IPECs discovered by us 
recently [13] comprise both IPEC (core) and PESC (corona) compartments, whose 
fractions can be varied in a broad range, and therefore, from our point of view, might be 
promising candidates for a design of novel separation membranes, e.g., via casting films 
from chloroform. Such films, which can be easily prepared, are expected to attractively 
combine membrane properties of both such complexes within a single material. 
 In this publication, we report on the interaction of a surfactant-modified ionic 
amphiphilic diblock copolymer polystyrene-block-poly(cetyltrimethylammonium acrylate) 
(PS-b-PA
-
 CTA
+
), with a surfactant-modified homopolyelectrolyte, poly(2-
(methacryloyloxyethyl)dimethylethylammonium dodecyl sulfate) (PDMAEMAQ
+
 DS
-
), 
which was derived from poly(2-(dimethylamino)ethyl methacrylate) via its quaternization 
with ethyl bromide followed by complexation of the quaternized product with sodium 
dodecyl sulfate, in chloroform. The obtained results strongly suggest that this interaction is 
a non-equilibrium process and can lead to macromolecular co-assemblies, which are 
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colloidally stable in chloroform or even chloroform-soluble, if one of the polymeric 
components is present in the certain excess and apparently have structure of micellar type. 
 
4.2 Experimental Part 
4.2.1 Materials 
 Monomers, t-butyl acrylate (t-BuA), styrene, and 2-(dimethylamino)ethyl methacrylate 
(DMAEMA), all donated by BASF SE, were stirred over CaH2, distilled from CaH2, and 
degassed in high vacuum. All other reagents were obtained from Aldrich. CuBr (95%) and 
CuCl (97%) were purified by stirring in acetic acid overnight. After filtration, they were 
washed with ethanol, then with ether, and afterwards dried under vacuum. N,N,N’,N”,N”-
pentamethyldiethylenetriamine (PMDETA, 99%) and ethyl-2-bromo-2-isobutyrate (EBIB, 
98%) were distilled and degassed. 1,1,4,7,10,10-Hexamethyltriethylenetetramine 
(HMTETA, 97%), p-toluenesulfonyl chloride (p-TsCl, 99%), trifluoroacetic acid 
(CF3COOH, 99%), ethyl bromide (EtBr, 99%), sodium dodecyl sulfate (SDS, 99%), 
cetyltrimethylammonium bromide, (CTAB) (99%), and chloroform (anhydrous, 99%) 
were used without further purification. 
 
4.2.2  Synthesis of Polymers 
 The syntheses of poly(acrylic acid) (PAA, Mn = 30000 g/mol, PDI = 1.08, DPn = 415) 
and of poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA, Mn = 61000 g/mol, PDI 
= 1.43, DPn = 390) followed by quaternization of the latter with EtBr to derive poly(2-
(methacryloyloxyethyl)dimethylethylammonium bromide) (PDMAEMAQ) are reported 
elsewhere [13]. Below, we describe in detail the synthesis of diblock copolymers 
polystyrene-block-poly(acrylic acid) (PS-b-PAAX) via atom transfer radical polymerization 
(ATRP), using polystyrene (PS) as a macroinitiator for polymerization of t-BuA, followed 
by acid-catalyzed hydrolysis of t-BuA moieties. All polymerizations were carried out 
inside a glovebox under nitrogen atmosphere. 
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  4.2.2.1 Synthesis of Polystyrene Macroinitiator.  
  CuBr (0.2754 g, 1.92 mmol), PMDETA (0.3328 g, 1.92 mmol), styrene (20 g, 0.192 
mol) and anisole (10 g, 50 wt%) were added in a round bottom flask and the mixture was 
stirred until complete dissolution of the copper complex. After the formation of the 
catalyst, the initiator, EBIB (0.3745 g, 1.92 mmol), was added. The flask was sealed and 
placed into an oil bath thermostated at 100°C for 2.5 h. The final conversion (48.5%) was 
determined by means of gas chromatography (GC). The reaction mixture was dissolved in 
acetone and treated with DOWEX ion exchange resin for 1 h and then passed through a 
silica column to remove the copper catalyst from the macroinitiator. The solvent was 
removed by rotating evaporation, the polymer was redissolved in ether and precipitated in 
methanol; this procedure was repeated twice. The purified PS macroinitiator was dried 
under vacuum and characterized by means of 
1
H NMR and gel permeation 
chromatography (GPC). The number-average molecular weight of the synthesized PS 
macroinitiator was Mn, PS = 8740 g/mol (PDI = 1.07), i.e., DPn, PS = 84. 
 4.2.2.2 Synthesis of Polystyrene-block-Poly(acrylic acid) (PS-b-PAAX) Diblock 
Copolymers.  
 Syntheses of two precursor polystyrene-block-poly(tert-butylacrylate) (PS84-b-PtBAX, 
Х denotes the DPn of the PtBA block) diblock copolymers was carried out under the 
similar conditions as those described above, except that PS was used as a macroinitiator 
and placed first together with CuBr. The general procedure is as follows. The PS 
macroinitiator, CuBr, t-BuA, and the solvent (50 wt % anisole) were put into a round-
bottom flask. After complete dissolution of the PS macroinitiator, the ligand, PMDETA, 
was added and an initial sample was taken as a reference to determine the conversion. The 
flask was finally sealed and placed into an oil bath thermostatted at 60°C. The final 
conversion was determined by means of GC. The obtained copolymers were purified by 
the same procedure that was used for the PS macroinitiator, although in this case a water-
methanol mixture (50/50 v/v) was used to precipitate the copolymers. Then, the precursor 
copolymers were analyzed by means of 
1
H NMR and GPC; their molecular weight 
characteristics are given in Table 1. To prepare the PS84-b-PAAX diblock copolymers, the 
t-BuA groups of the precursor copolymers were hydrolyzed for 24 h using a 5-fold excess 
of CF3COOH in CH2Cl2 at room temperature. The precipitated polymers were separated, 
washed with CH2Cl2, dried under vacuum, and then purified using soxhlet extraction with 
toluene to remove traces of PS. The quantitative hydrolysis of the t-BuA groups of the 
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prepared copolymers was confirmed by means of 
1
H NMR through the disappearance of 
the signals corresponding to the protons of the t-butyl groups (δ = 1.5 ppm). As PS84-b-
PAAX diblock copolymers cannot be directly analyzed by means of GPC in THF, their 
purity was confirmed using a procedure developed by Zhang et al. [19]. Briefly, 
copolymers are dissolved in THF and the PAA blocks are neutralized with a concentrated 
solution of NaOH to yield poly(sodium acrylate) (PANa). As is seen, only peak was 
observed (Fig. 1), which can be reasonably attributed to reversed micelles of the PS84-b-
PANaX diblock copolymers, each comprises a PANa core and a PS corona, which form in 
THF, hereby indicating successful purification. 
Table 1. Experimental Conditions and Results of the Synthesis of PS84-b-PtBAX 
PS84-b-PtBAX 
copolymer
a
 
[M]0:[I]0:[Cu]:[L] Mn, PS-b-PtBA
b
, g/mol 
(PDI)
c
 
wt-BA, 
% 
wAA, 
% 
PS84-b-PtBA115 120:1:1:1 25300  
(1.16) 
65.5 48.7 
PS84-b-PtBA410 520:1:1:1 61300  
(1.26) 
85.7 77.2 
a
Mn, PS = 8740 g/mol (PDI = 1.07) from GPC analysis in THF using PS calibration. 
b
Determined by 
1
H 
NMR. 
c
From GPC analysis in THF using PtBA calibration.  
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Figure 1. GPC traces of the precursor PS84 (
______
), PS84-b-PtBA115 (------) and reverse 
micelles of PS84-b-PANa115 (--∙--∙--) after extraction of the residual PS. THF was used as 
the eluent. 
 
4.2.3 Preparation of Polyelectrolyte-Surfactant Complexes (PESCs)  
 PDMAEMAQ was dissolved in Millipore water. PS84-b-PAAX diblock copolymers 
were dissolved upon heating at ca. 100 C under continuous stirring in 0.01 M TRIS HCl 
buffer (pH 9) containing the equivalent molar amount (with respect to carboxylic groups of 
the copolymers) of NaOH. SDS was dissolved in Millipore water while CTAB was 
dissolved in 0.01 M TRIS HCl buffer (pH 9). PESCs were successfully synthesized with a 
yield of more than 90% according to a procedure reported in our previous publication [10]. 
Specifically, the aqueous solution of the surfactant was added to an aqueous solution of the 
oppositely charged polyelectrolyte or ionic amphiphilic diblock copolymer at 0.1 M NaCl 
until 1 : 1 ratio between molar concentrations of ionic groups of the polymeric component 
and the surfactant was reached. At this concentration ratio, the formed PESCs precipitated. 
Then, ca 5 % molar excess of the surfactant was added. Afterwards, the PESCs, referred to 
as PS84-b-(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS
-
, respectively, were filtered under vacuum 
using a funnel with a glass frit and rinsed with distilled water to remove unreacted 
surfactant and low molecular weight salt. Next, the PESCs were dried at 40°C for 4 h and 
then under vacuum at room temperature for 10 days. The degree of substitution of the 
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small counterions by the corresponding surfactant counterions was determined by means of 
elemental analysis of nitrogen content for PS84-b-(PA
-
 CTA
+
)X while by means of 
elemental analysis of sulfur and nitrogen contents (S/N ratio) for PDMAEMAQ
+
 DS
-
 
(Table 2). The obtained PESCs easily dissolved in chloroform, yielding absolutely 
transparent solutions even at rather high polymer concentrations. 
 
Table 2. Results of the Elemental Analysis of PESCs. 
 
PESC 
 
N, % (calc.) 
 
S, % (calc.) 
degree of substitution of 
small counterions, % 
PS84-b-(PA
-
 CTA
+
)115 3.27 (3.24) - 100 
PS84-b-(PA
-
 CTA
+
)410 3.69 (3.72) - 99 
(PA
-
 CTA
+
)415 3.38 (3.90) - 87 (Ref.[13]) 
PDMAEMAQ
+
 DS
-
 2.65 (2.85) 6.08 (6.53) 98
 
(Ref. [13]) 
 
4.2.4. Characterization  
  Gel Permeation Chromatography (GPC).  
Molecular weight distributions were measured by means of GPC with THF or in the case 
of PDMAEMA with THF containing tetrabutylammonium bromide as the eluents. The 
instrument was operated at a flow rate of 1.0 mL/min at room temperature. A column set, 
5  SDV gel, 10
2–105 Å, 30 cm each (PSS, Germany), was used together with a differential 
refractometer and an UV detector operated at the wavelength of 254 nm. PS and poly(tert-
butyl methacrylate) standards (PSS, Germany) were used for the calibration of the column 
set. 
 Turbidimetric Titrations  
Measurements were carried out with a Perkin-Elmer Lambda 15 UV/vis spectrophotometer 
at the wavelength of 500 nm. At this wavelength, the (co)polymers do not absorb light; 
therefore, optical density values are attributed only to the light scattering. The molar 
concentrations of a titrand and a titrant in terms of (A
-
 CTA
+
) or (DMAEMAQ
+
 DS
-
) were 
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4.29 mM and 42.9 mM, respectively. The time interval between successive additions of a 
titrant was equal to 4 min. 
 Dynamic Light Scattering (DLS).  
Size distributions of co-assemblies formed in chloroform mixtures of PS-b-(PA
-
 CTA
+
)X 
and PDMAEMAQ
+
 DS
-
 were determined by means of DLS with an ALV DLS/SLS SP 
5022F equipment and a He-Ne laser (  = 632.8 nm) as a light source. The total polymer 
concentrations were ranging between 1 and 3 mg/mL. Prior to measurements, sample 
mixtures were filtered using PTFE filters (Millipore) with a pore size of 1 µm. The 
CONTIN program was employed to analyze the autocorrelation functions measured at the 
scattering angle of 90  and at room temperature. 
  Static Light Scattering (SLS).  
Molecular weight characteristics of co-assemblies formed in chloroform mixtures of PS-b-
(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS
-
 were determined by means of SLS. A mother 
mixture of the polymeric components in chloroform at the specified molar mixing ratio Z* 
= 0.4 between the (A
-
 CTA
+
) units and the (DMAEMAQ
+
 DS
-
) units, Z* = [PA
-
 CTA
+
]/[PDMAEMAQ
+
 DS
-
], was prepared at the concentration of PDMAEMA
+
 DS
-
 in its 
mixtures with PS-b-(PA
-
 CTA
+
)X equal to ca. 2.6 g/L. Then, a set of sample mixtures was 
prepared by subsequent dilutions of the obtained mother mixture with chloroform to cover 
a concentration range for PDMAEMA
+
 DS
-
 between 0.6 to 2.6 g/L. Afterwards, the sample 
mixtures were thoroughly filtered using PTFE filters with a pore size of 1 µm. SLS 
measurements were carried out at room temperature on a Sofica goniometer equipped with 
a He-Ne laser (λ = 632.8 nm). The data were analyzed by Berry extrapolation. Refractive 
index increments, dn/dc, were measured at room temperature with a differential 
refractometer (Dn/Dc 2010/620, PSS, λ = 620 nm). The dn/dc values determined for the 
interpolyelectrolyte complexes in chloroform PS84-b-(PA- CTA+)X with 
PDMAEMAQ+ DS
-
 at Z* = 0.4 are: 0.029 ± 0.003 for PS84-b-(PA
-
 CTA
+
)115, 0.083 ± 
0.001 for PS84-b-(PA
-
 CTA
+
)410, and 0.0266 ± 0.0007 for (PA
-
 CTA
+
)415. 
  Transmission Electron Microscopy (TEM). 
TEM images were taken using a Zeiss EM 922 transmission electron microscope operated 
at 200 kV. Typically, a 5 L droplet of a sample solution in chloroform was deposited onto 
a copper TEM grid coated with a carbon film. Zero/loss filtered images ( E = 0 eV) were 
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taken under reduced dose conditions (100–1000 e/nm2). All images were registered 
digitally by a bottom-mounted CCD camera system (Ultrascan 1000, Gatan, München, 
Germany) combined and processed with a digital imaging processing system (Digital 
Micrograph 3.9 for GMS 1.4, Gatan). 
 
 
4.3 Results and Discussions 
4.3.1. Interpolyelectrolyte Complexation in Chloroform 
 After being thoroughly dried, the PESCs, PS84-b-(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS
-
, 
prepared as described in the Experimental Section, were each dissolved in anhydrous 
chloroform, giving absolutely transparent solutions. On addition of a chloroform solution 
of PDMAEMAQ
+
 DS
-
 to a chloroform solution of PS84-b-(PA
-
 CTA
+
)X, opalescence 
appears already at rather low molar mixing ratios, Z, between the (DMAEMAQ
+
 DS
-
) units 
and the (A
-
 CTA
+
) units, Z = [PDMAEMAQ
+
 DS
-
]/[PA
-
 CTA
+
], thus indicating the 
formation of IPECs assembled from the PA
-
 blocks and PDMAEMAQ
+
 chains, while the 
surfactant counterions (CTA
+
 and DS
-
) are released into the bulk solution in the form of 
surfactant ion pairs or their aggregates. Such opalescent mixtures of the complementary 
PESCs remain stable on the colloidal level at molar mixing ratios Z  ca 0.2 (Fig. 2A). For 
Z > 0.6, the transmittance remains nearly constant with further addition of the titrant. As is 
also seen, the presence of the PS block in one of the polymeric components does not cause 
the mixtures of the complementary PESCs to be less turbid as it might be intuitively 
expected since chloroform is a good solvent for PS. Moreover, the increasing content of PS 
in PS84-b-(PA
-
 CTA
+
)X for X = 115 as compared to X = 410 apparently makes such 
mixtures even more turbid. In the case of addition of a chloroform solution of PS84-b-(PA
-
 CTA
+
)X to a chloroform solution of PDMAEMAQ
+
 DS
-
, the mixtures of the 
complementary PESCs appear to remain transparent or slightly opalescent at molar mixing 
ratios Z*  ca 0.6 between the (A
-
 CTA
+
) units and the (DMAEMAQ
+
 DS
-
) units (Fig. 2B), 
Z* = [PA
-
 CTA
+
]/[PDMAEMAQ
+
 DS
-
]. This finding strongly suggests the formation of 
chloroform-soluble IPECs in the case of at least 1.5-fold or more molar excess of the 
(DMAEMAQ
+
 DS
-
) units in the mixtures of the complementary PESCs. The excess 
fragments (tails/loops) of PDMAEMAQ
+
 DS
-
 are considered to provide a stabilization 
effect for the formed IPECs. A similar behavior was observed for a reference system, that 
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is, for a chloroform solution of PDMAEMAQ
+
 DS
-
 titrated with a chloroform solution of 
(PA
-
 CTA
+
)415 (cf. Fig. 2B, squares and also Ref. [13]). It is also worthy to emphasize that 
at Z* < 1 turbidimetric titration curves for chloroform solutions of PDMAEMAQ
+
 DS
-
 
titrated with chloroform solutions of PS84-b-(PA
-
 CTA
+
)X as well as with a chloroform 
solution of (PA
-
 CTA
+
)415 demonstrate only small differences. 
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Figure 2. Turbidimetric titration curves of (A) chloroform solutions of PS84-b-(PA
-
 CTA
+
)X with a chloroform solution of PDMAEMAQ
+
 DS
-
 and (B) a chloroform solution 
of PDMAEMAQ
+
 DS
-
with chloroform solutions of PS84-b-(PA
-
 CTA
+
)X. The turbidimetric 
titration curves of a chloroform solution of (PA
-
 CTA
+
)415 with a chloroform solution of 
PDMAEMAQ
+
 DS
-
 or vice versa are also given in both plots for a comparison purpose. 
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The dashed vertical lines denote boundaries between colloidally stable or soluble IPECs (to 
the left of) and insoluble IPECs (to the right of). 
 
4.3.2  Characterization of IPECs 
 Transparent (or slightly opalescent) chloroform mixtures of PS84-b-(PA
-
 CTA
+
)X and 
PDMAEMAQ
+
 DS
-
 were at first examined by means of DLS. Typical size distributions 
(following from CONTIN analysis of the obtained autocorrelation functions) of the 
scattering particles formed in mixtures of PS84-b-(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS
-
 at 
Z* = 0.4 (2.5-fold molar excess of the (DMAEMAQ
+
 DS
-
) units) are given in Fig. 3. These 
distributions are obviously characterized by a dominant contribution to the intensity of the 
scattered light from particles with <Rh>z = 75 – 80 nm. A very similar size distribution was 
obtained for chloroform mixtures of (PA
-
 CTA
+
)415 and PDMAEMAQ
+
 DS
-
 (Fig. 3). In 
analogy to previous assignments [13] of the scattering particles formed in chloroform 
mixtures of (PA
-
 CTA
+
)415 and PDMAEMAQ
+
 DS
-
, such rather large scattering particles 
are attributed to aggregated IPECs resulting from the interaction between PS84-b-
(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS
-
. Smaller scattering species with <Rh>z  6 nm (the 
mixture of (PA
-
 CTA
+
)415 with PDMAEMAQ
+
 DS
-
) or <Rh>z  20 nm (the mixture of 
PS84-b-(PA
-
 CTA
+
)410 with PDMAEMAQ
+
 DS
-
) (indicated by arrows in Fig. 3) could be 
observed in the corresponding size distributions but give a small or even negligible 
contribution to the intensity of the scattered light. These much smaller scattering species, 
as is already mentioned in our previous publication [13], may be considered as either 
precursors of the large co-assemblies resulting from the secondary aggregation of the 
initially generated IPECs or single PESC unimers that are not involved in the 
interpolyelectrolyte complexation. 
 In the case of IPEC particles formed upon addition of a chloroform solution of PS84-b-
(PA
-
 CTA
+
)X to a chloroform solution of PDMAEMAQ
+
 DS
-
 (a molar excess of the 
(DMAEMAQ
+
 DS
-
) units), their hydrodynamic radii were found to considerably decrease 
with lowering Z* from Z* = 0.4 to Z* = 0.2 (Table 3), thereby presumably indicating the 
formation of less aggregated IPECs, which therefore comprise lower numbers of 
macromolecules of the constituting polymeric components. It is also interesting that the 
values of <Rh>z of the aggregated IPECs in chloroform mixtures of PS84-b-(PA
-
 CTA
+
)X or 
(PA
-
 CTA
+
)415 with PDMAEMAQ
+
 DS
-
 appear to be only marginally dependent on 
whether IPEC species are formed at the 5-fold molar excess of the (DMAEMAQ
+
 DS
-
) 
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units (Z* = 0.2) or at the 5-fold molar excess of the (A
-
 CTA
+
) units (Z = 0.2) in the 
mixtures of the complementary PESCs. 
 
1 10 100 1000
10
-4
10
-3
10
-2
10
-1
10
0
10
1
10
2
10
3
0.0
0.2
0.4
0.6
0.8
1.0
 
 
g
2
(t
)-
1
Lag time, ms  
 
 PS
84
-b-(PA
-
 CTA
+
)
115
 PS
84
-b-(PA
-
 CTA
+
)
410
(PA
-
 CTA
+
)
415
n
o
rm
a
li
ze
d
 i
n
te
n
s
it
y
hydrodynamic radius, nm  
Figure 3. Intensity-weighted distributions of apparent hydrodynamic radii, <Rh>z, of the 
scattering particles formed in chloroform mixtures of PS84-b-(PA
-
 CTA
+
)X and 
PDMAEMAQ
+
 DS
- 
at Z* = 0.4 (2.5-fold molar excess of the (DMAEMAQ
+
 DS) units). 
The corresponding size distrubution for the chloroform mixture of (PA
-
 CTA
+
)415 is also 
given for a comparison purpose. Total concentration of PDMAEMAQ
+
 DS
-
 (the excess 
polymeric component) was equal to 2.6 g/L. 
 
 
Table 3. Apparent hydrodynamic radii, <Rh>z, of the aggregated IPECs formed in the 
chloroform mixtures of PS84-b-(PA
-
 CTA
+
)X with PDMAEMAQ
+
 DS
-
 
 <Rh>z, nm 
Z* = 0.2 
<Rh>z, nm 
Z* = 0.4 
<Rh>z, nm 
Z = 0.2 
PS84-b-(PA
-
 CTA
+
)115 42 80 44 
PS84-b-(PA
-
 CTA
+
)410 51 76 61 
(PA
-
 CTA
+
)415 64 76 65 
 
 Since small scattering particles give only a minor contribution to the intensity of the 
scattered light, SLS measurements to evaluate the molecular weight characteristics of the 
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large co-assemblies formed upon the interaction between PS84-b-(PA
-
 CTA
+
)X and 
PDMAEMAQ
+
 DS
-
 are feasible. As a representative example, Fig. 4 shows a typical Berry 
plot for the chloroform mixture of PS84-b-(PA
-
 CTA
+
)115 with PDMAEMAQ
+
 DS
-
 at Z* = 
0.4 (2.5-fold molar excess of the (DMAEMAQ
+
 DS
-
) units). Extrapolations of 
(Kc/R)
1/2
ϴ→0 and (Kc/R)
1/2
c→0 are close to linear within the used concentration range. 
Besides, DLS measurements do not give any evidence for considerable changes of 
hydrodynamic size of the IPEC species, at least in the concentration range from 1 to 3 g/L 
with respect to PDMAEMA
+
 DS
-
. Thus, both SLS and DLS measurements suggest that the 
IPECs formed in chloroform are stable macromolecular co-assemblies, which demonstrate 
no tendency to their disintegration or dissociation upon dilution of the system with 
chloroform. This is naturally expected, as the Coulomb attraction in organic media of low 
permittivity is very strong. 
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Figure 4. Typical Berry plot obtained for the chloroform mixture of PS84-b-(PA
-
 CTA
+
)115 
and PDMAEMAQ
+
 DS
- 
at Z* = 0.4 (2.5-fold molar excess of the (DMAEMAQ
+
 DS
-
) 
units). 
 
 Table 4 shows that the weight-average molecular weights, Mw, of the formed IPEC 
species are within Mw = 10
8
 – 109 g/mol, at least three orders of magnitude higher than 
those of the precursor PESCs. This finding provides clear evidence for interpolyelectrolyte 
complexation and suggests that the co-assemblies formed comprise a large number of 
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macromolecules of the constituting polymeric components. The positive values of the 
second virial coefficient (A2 = 10
-7
 – 10-6 mol ml/g2), indicate that chloroform should be a 
good solvent for the IPEC species formed. The ratio ρ = <Rg
2
>
0.5
/Rh, which characterizes 
the shape of the scattering particles, ranges from 1.18 to 1.24, thus being in good 
agreement with the values for star-shaped polymers with a high number of arms [20]. At 
the same time, the decreasing length of the PA
-
 CTA
+ 
block in the polymeric component to 
be interacted with PDMAEMAQ
+
 DS
-
 significantly decreases molecular weight of the 
IPEC species, thus indicating smaller number of macromolecules of the constituent 
polymeric components incorporated into them. 
 
Table 4. SLS/DLS results for the IPEC particles formed in the chloroform mixtures of 
PS84-b-(PA
-
 CTA
+
)X with PDMAEMAQ
+
 DS
-
 at Z* = 0.4 (2.5-fold molar excess of the 
(DMAEMAQ
+
 DS
-
) units) 
 10
-8
 
Mw, 
g/mol 
10
-3
 Nagg 
(NPS-b-PA
-
 + 
NPDMAEMAQ
+
/PDMAEMAQ
+
DS
-
) 
10
7
 A2, 
mol ml/g
2
 
<Rh>z, 
nm 
<Rg
2
>
0.5
, 
nm 
ρ 
 
PS84-b-(PA
-
 CTA
+
)115 3.05 4.6 
(2.6 + 8.9) 
5.16 80 94 1.18 
PS84-b-(PA
-
 CTA
+
)410 9.60 8.9 
(2.5 + 6.4) 
8.46 76 90 1.18 
(PA
-
 CTA
+
)415 2.29 2.2 
(0.6 + 1.6) 
1.24 76 95 1.24 
 
 From the values of Mw given in Table 4, we estimate the total number of polymer 
chains in each particle, Nagg. Here we assume that the molar stoichiometry of the formed 
IPEC coincides with the molar mixing ratio of the complementary polymeric components 
and all surfactant counterions of those (DMAEMAQ
+
 DS
-
) and (A
-
 CTA
+
) units that form 
interpolymer salt bonds are released. The estimated numbers of PS-b-PA
-
 and 
PDMAEMAQ
+
/PDMAEMAQ
+
 DS
-
 chains in each complex are given in parentheses. 
Under the assumptions made, the numbers represent upper limits. To determine Nagg, we 
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first calculate the theoretical molecular weight, Mcalc, for an IPEC comprising only one 
chain of PS-b-PA
-
, taking into account a 2.5-fold molar excess of the (DMAEMAQ
+
 DS
-
) 
units over (A
-
 CTA
+
) units in the mixture of the complementary PESCs at Z* = 0.4: 
calc PS PAA PAA(DMAEMA A ) (DMAEMA DS )
1
M M DP M DP 1 M
Z*
                                      (1) 
Then 
PS b PA
N  is calculated as 
w
PS b PA
calc
M
N
M
                                                        (2) 
and 
PDMAEMAQ /PDMAEMA DS
N  is given by 
PAA
PDMAEMAQ /PDMAEMAQ DS PS b PA
PDMAEMAQ
DP
N N Z*
DP
                          (3). 
 The estimated values of Nagg are also presented in Table 4, indicating that the formed 
IPEC species appear to be built up from thousands of chains of the polymeric components. 
It is surprising that the presence of the PS block in one of the polymeric components does 
not facilitate the formation of less aggregated IPEC species in chloroform. Indeed, the 
values of Nagg for IPECs formed in the mixtures of PDMAEMAQ
+
 DS
-
 and PS84-b-(PA
-
 CTA
+
)X considerably exceed those IPECs formed in the mixture of PDMAEMAQ
+
 DS
-
 
and (PA
-
 CTA
+
)415 (Table 4). This finding manifests a strong tendency of 
(PDMAEMAQ
+
 PA
-
) fragments to aggregation despite of the presence of excess 
PDMAEMAQ
+
 DS
-
 fragments and PS blocks, both PDMAEMAQ
+
 DS
-
 fragments and PS 
blocks being well-soluble in chloroform. 
 The morphology of IPEC species formed in chloroform mixtures of PS84-b-(PA
-
 CTA
+
)410 and PDMAEMAQ
+
 DS
-
 at Z* = 0.4 (2.5-fold molar excess of the 
(DMAEMAQ
+
 DS
-
) units) was also investigated by means of TEM. The obtained 
micrographs (Fig. 5) indicate particles of close to spherical shape (sometimes deformed 
spherical shape), apparently with inhomogeneous structure. Furthermore, the observed 
species are characterized by a rather broad size distribution (<RTEM>n = 34 ± 9 nm as 
calculated from Fig. 5B for 136 objects). The TEM micrographs obtained for a comparison 
purpose for the precursor PESCs, PS84-b-(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS
-
 (results are 
not shown), demonstrate no objects similar to those seen in Fig. 5. The high polydispersity 
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of IPECs generated in such systems may be reasonably attributed to the formation of 
substantially “frozen” structures in low-polarity organic media. The fact that the value of 
<RTEM>n is ca 2-times lower than the value of <Rh>z can be attributed to a collapse of the 
IPEC species upon drying as well as the different averages. The inhomogeneity of the 
observed species might be attributed to incidental entrapping of PS blocks into a core 
assembled from the oppositely charged fragments of PA
-
 and PDMAEMAQ
+
 as a 
consequence of the pronounced non-equilibrium character of the interpolyelectrolyte 
complexation in low-polarity organic solvents. 
 
 Figure 5. TEM images of IPEC particles formed in the chloroform mixture of PS84-b-(PA
-
 CTA
+
)410 and PDMAEMAQ
+
 DS
-
 at Z* = 0.4 (2.5-fold excess of the (DMAEMAQ
+
 DS
-
) 
units). 
 
4.3.3. Tentative Structure of IPECs 
 We anticipated that the interaction between the complementary PESCs in the excess of 
one of the polymeric components would result in macromolecular co-assemblies of a 
micellar (core-corona) type. A rather compact core assembled from the oppositely charged 
fragments of PA
-
 and PDMAEMAQ
+
 substantially represents a stoichiometric IPEC 
comprising the opposite charges of the polymeric components in ca 1 : 1 ratio. In the 
excess of PS84-b-(PA
-
 CTA
+
)X, the solubilizing corona should be formed by the PS blocks 
and those fragments of the PA
-
 CTA
+
 blocks, which are not involved in the 
 
  
 
A B 
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interpolyelectrolyte complexation (Fig. 6, right structure). In the excess of 
PDMAEMAQ
+
DS
-
, the solubilizing corona comprises both the PS blocks and those 
fragments of the PDMAEMAQ
+
DS
-
 blocks, which are not involved in the 
interpolyelectrolyte complexation (Fig. 6, left structure). Thus, the macromolecular co-
assemblies formed due to the interaction between PS84-b-(PA
-
 CTA
+
)X and 
PDMAEMAQ
+
 DS
-
 in chloroform can be considered as peculiar IPEC/(PESC/PS) 
nanoparticles of core-corona type, each comprising an IPEC core surrounded by a mixed 
PESC/PS corona. At the same time, we cannot exclude the possibility that a certain part of 
the PS blocks is incidentally entrapped into the core assembled from the oppositely 
charged fragments of PA
-
 and PDMAEMAQ
+
. Indeed, the Coulomb attraction between 
such oppositely charged fragments is very strong in low-polarity organic media, such as 
chloroform (  = 4.8), thereby leading to substantially non-equilibrium, “frozen” and 
therefore non-ideal structures, which cannot rearrange once they are formed. Such 
entrapment of the PS blocks into (PA
-
 PDMAEMAQ
+
) cores of the resultant 
macromolecular co-assemblies may explain, at least partially, their somewhat 
inhomogeneous structure, which is apparently observed in the TEM images (Fig. 5). 
 
 
Figure 6. Schematic representation of tentative, idealized structures of macromolecular co-
assemblies formed in chloroform mixtures of PS84-b-(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS. 
 
4.4 Conclusions 
 We demonstrate the formation of novel macromolecular co-assemblies with 
hydrodynamic radii in the range of 40 – 80 nm due to the interaction between two 
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complementary PESCs, viz., PS84-b-(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS
-
, in chloroform. 
Such co-assemblies can be either colloidally stable or even soluble if one of the PESCs is 
present in the system in the certain excess. We suggest the formed colloidally stable or 
soluble co-assemblies to be aggregates of micellar type with an IPEC core surrounded by 
apparently a mixed PESC/PS corona, which grants such co-assemblies solubility in 
chloroform (good solvent for both PESC and PS). As the electrostatic interaction in low-
permittivity organic media is naturally expected to be very strong, the described above co-
assemblies are most likely non-equilibrium (“frozen”) macromolecular architectures, 
whose IPEC cores may contain quite a few PS blocks incidentally entrapped upon the 
formation of the complex species. Overall, the co-assemblies formed in the chloroform 
mixtures of PS84-b-(PA
-
 CTA
+
)X and PDMAEMAQ
+
 DS
-
 at Z (or Z*)  1 apparently 
represent peculiar compartmentalized nanoparticles of core-corona type, which due to the 
presence of both IPEC (core) and PESC (corona) compartments may possess a number of 
unique properties and promising applications. 
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Abstract 
New Melatonin-loaded vesicular nanocarriers were prepared by interfacial deposition 
using a blend of an amphiphilic diblock copolymer, poly(methyl methacrylate)-block-
poly(2-(dimethylamino)ethyl methacrylate), PMMA-b-PDMAEMA, with poly( -
caprolactone), PCL. Particle size and morphology of the nanocarriers was evaluated. 
Dynamic light scattering shows that the nanocarriers have hydrodynamic radii between 
100 and 180 nm, with unimodal particle size distribution for each formulation. Shape and 
structure were visualized by transmission electron microscopy (TEM), cryogenic TEM and 
scanning electron microscopy. Standard TEM for nanocapsules showed an oily core 
surrounded by a thin layer composed by PCL/PMMA-b-PDMAEMA. Cryo-TEM also 
indicated the presence of spherical nanoobjects with a diffuse polymer corona. 
Encapsulation efficiencies were determined assaying the nanoparticles by HPLC and 
higher values of ca. 25% are shown by the nanocapsules. We could successfully 
incorporate platinum nanoparticles into the nanocarrier as evidenced by TEM, which opens 
up the possibility for promising applications like monitoring the encapsulated drug in the 
body. 
 
 
Keywords: nanocapsules, amphiphilic block copolymer, caprolactone, PDMAEMA, 
melatonin, cryo-TEM, DLS,  
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5.1. Introduction 
 Polymeric nanoparticles refer to nanocarriers prepared using polymers, i.e., 
nanocapsules and nanospheres. A nanocapsule (NC) has a vesicular structure, composed of 
a central oil core surrounded by a thin polymer wall, whereas a nanosphere (NS) only 
consists of a polymer matrix. NC and NS are stabilized by surfactants at the particle/water 
interface, preventing particle agglomeration and/or drug leakage. These colloidal systems 
(NC and NS) can be prepared either by polymerization of dispersed monomers, so called 
interfacial polymerization, or using pre-formed polymers by nanoprecipitation, also called 
interfacial deposition or solvent displacement,
1,2
  solvent evaporation,
3
 or emulsion-
diffusion techniques.
4
 By interfacial polymerization, alkyl cyanoacrylate monomers have 
been commonly used.
5,6
 Here, the cyanoacrylate monomer is polymerized in the presence 
of the lipophilic drug. Both monomer and drug are previously dissolved in a mixture of oil 
and lipophilic solvent. Moreover, the presence of residual monomers or oligomer, as well 
as the cross-reaction between the components might limit the potential of the 
nanocapsules. This problem was overcome by Fessi by means of interfacial deposition of 
preformed polymers.
1
 Nanocapsules are formed instantaneously by the fast diffusion of a 
water-miscible solvent with the polymer, drug and oil into an aqueous solution. In general 
mixture of surfactants and/or stabilizers is used to avoid drug leakage and/or flocculation 
and sedimentation of particles. 
 Some free or unencapsulated oral administered drugs have shown a low bioavailability 
that can mainly be attributed to the premature degradation and/or poor solubility of drugs 
in the gastrointestinal tract. In the literature, there are several reports on the encapsulation 
of some drugs has enhanced the absorption and bioavailability compared to oral-free drugs. 
7-10
 The development of drug delivery systems from biodegradable polymers has been 
gaining great interest because of their multiple advantages for a better control of drug 
release to achieve a more effective therapy against some diseases. These systems help to 
minimize drug degradation, reduce its toxicity after the administration, keep the drug level 
in a desired range and increase the drug availability at the disease site. Drug carriers can 
include micelles, liposomes, polymeric nanoparticles and nanoemulsions.
11-14
 
 The aim of this work was to obtain a new vesicular nanocarrier using a blend of 
poly(epsilon-caprolactone), PCL, and poly(methyl methacrylate)-b-poly(2-
dimethylaminoethyl methacrylate), PMMA-b-PDMAEMA. PCL is a linear polyester 
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widely use as polymer wall in NC, whereas PMMA-b-PDMAEMA has been reported to 
form micelles in aqueous media, for neutral or cationic PDMAEMA block.
15-17
 
Amphiphilic diblock copolymers have been widely used due to their promising 
applications.
13,18-20
 Our strategy is based on the hypothesis that a new generation of 
vesicular carrier can be built directly by the mixture of both polymers in acetone with no 
need of any surfactant, like polysorbates, phopholipids, sorbitan monostearate or sorbitant 
monooleate, or stabilizer, as poly(ethyleneglycol) or poloxamers, among others. PMMA-b-
PDMAEMA was chosen because of its ability to anchor at the polymer wall of 
nanocapsules and to interact with water at the interface. This diblock presents good 
solubility in acetone, a solvent which can diffuse through water, allowing the preparation 
of those new vesicular nanocarriers under similar conditions previously used to obtain 
conventional NC. The hydrophilic PDMAEMA is a pH and temperature-sensitive polymer 
with lower critical solution temperature (LCST),
21
 and it is gaining great interest in the 
industrial and research field because its potential applications as emulsion and dispersion 
stabilizer, flocculants for water and wastewater treatment, drug delivery, etc.
22-24
 For 
instance, the amino function in the PDMAEMA chain can be complexed with metallic 
nanoparticles as a potential way to monitor particle migration inside the body. In the 
particular case of polymeric nanocarriers, it can lead to avoid the use of hydrophilic low 
molecular weight surfactants as stabilizers, traditionally employed for this type of 
formulations, and it might improve the absorption of orally administered drugs, as shown 
by Sakuma, who demonstrated that the presence of hydrophilic polymeric chains onto 
hydrophobic polystyrene surfaces can enhance the absorption in the intestine of orally 
administered salmon calcitonin.
25-27
 In our first attempt using the PCL/PMMA-b-
PDMAEMA block copolymer blend, the new vesicular nanocarriers were prepared by 
interfacial deposition technique. In order to evaluate the ability of those nanocarriers in 
encapsulating lipophilic drugs, melatonin was used as drug model, due to its relevance in 
the field of Health Sciences. 
 The hormone melatonin, N-acetyl-5-methoxytryptamine, (Chart 1), is a major product 
of the pineal gland in our brain. This hormone is synthesized in our body during the night, 
and its production decreases with age and has an important role in the regulation of 
physiological processes like circadian and seasonal changes.
28
 It is a well-known 
antioxidant and a free radical scavenger
29,30 
as well as a suppressor of lipid peroxidation.
31
 
Furthermore, its properties have been investigated to treat sleep disorders,
32,33
 and 
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neurodegenerative diseases,
34-36
 such as Alzheimer, Parkinson and Huntington. 
Additionally, it is adopted as anti-inflammatory and anti-cancer agent.
37
 
Chart 1. Melatonin Structure. 
 
 
 Melatonin has a short half-life of less than 1 hour and a nocturnal secretion pattern over 
8 h. When administered orally, it shows a low and variable bioavailability and hence is not 
a good candidate for conventional immediate-release oral technology. As such, much of 
the current efforts have been focused on the development of sustained release forms for 
melatonin.
38,39
 It has been reported that exogenous controlled-release melatonin 
formulations are clinically more useful for sleep maintenance than fast released melatonin 
formulations.
32
 Tusilli
40
 reported that the photostability of melatonin could be enhanced by 
its encapsulation into lipid microspheres. El-Gibaly et al.,
39
 investigated melatonin-loaded 
microparticles with a hollow core, which presented encapsulation efficiencies between 
36.9-56.2%. They could also evaluate its efficacy against cases of aflatoxicosis, where 
melatonin microcapsules appeared to be more effective in the reduction of the apoptotic 
rate than free melatonin. 
 Melatonin-loaded nanoparticles have been reported by Schaffazick et al.
41,42
 The 
encapsulation was carried out using Eudragit S100
®
, and it was demonstrated that c.a. 55% 
of the drug can be encapsulated inside nanocapsules and nanospheres, and 32% in the 
nanoemulsions. Additionally, nanoparticulates showed a notable increase in the antioxidant 
properties of melatonin against lipid peroxidation. 
 To ensure the quality of the new vesicular nanocarrier suspensions, the colloids were 
characterized using dynamic light scattering (DLS), probe content (HPLC), standard and 
cryogenic transmission electron microscopy (TEM and cryo-TEM) and scanning electron 
microscopy (SEM). 
O
NH
NH
O
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5.2. Experimental Section 
5.2.1 Materials  
 Two amphiphilic diblock copolymers poly(methyl methacrylate)-b-poly(2-
dimethylaminoethyl methacrylate) (M40D108 and M40D471), with the same PMMA block 
length were synthesized by the ATRP technique. All other chemicals were purchased and 
used without any further purification: Poly( -caprolactone), PCL (Mw = 65.000 g/mol, 
Aldrich). Miglyol 810
® 
(caprylic/capric triglyceride, oil phase, Hulls, France), melatonin 
(99% purity, Acros Organic). 
5.2.2 Synthesis of Poly(methyl methacrylate) macroinitiator 
 Polymerization was carried out as reported by Matyjaszewski et al.
43
 Methyl 
methacrylate monomer (20 g, 0.2 mol) was added to a round bottom flask containing CuCl 
(19.8 mg, 0.2 mmol), 4,4’-di(5-nonyl)-2,2’-bipyridyl (dNbpy) (81.8 mg, 0.2 mmol) and 
anisole (10.0 g, 50 wt%). p-toluene sulfonyl chloride, p-TsCl, (0.381 g, 2.0 mmol) was 
used and initiator and a first sample was removed for conversion determination. The flask 
was sealed with a plastic cap and reaction solution was immersed into an oil bath 
thermostated at 90 °C for 5h. Final conversion was determined by GC.  
5.2.3 Synthesis of Poly(methyl methacrylate)-b-poly(2-dimethylaminoethyl methacrylate) 
 DMAEMA was copolymerized using PMMA as macroinitiator, CuCl and 1,1,4,7,10,10-
hexamethyltriethylenetetramine, HMTETA, as catalyst system in anisole. The flask was 
sealed with a plastic cap, and immersed into an oil bath at 90 °C. Conversion was 
determined by GC and the polymer was purified first by passing it through a silica column 
using THF as eluent to remove the catalyst and then precipitating the copolymer into 
hexane. The copolymers were characterized by 
1
H-NMR and GPC. Table 1 shows the 
chemical characterization and compositions for both copolymers.  
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TABLE 1. Molecular Characterization of PMMA-b-PDMAEMA 
Polymer Mn, PMMA
a
 (PDI) Mn,diblock
b
 (PDI)
b
 
b
Composition (%PMMA) 
M40D108 4.000 (1.11) 21.000 (1.15) 23% 
M40D471 4.000 (1.11) 78.000 (1.11) 6% 
a) From GPC analysis in THF using PMMA calibration. 
b) From 1H-NMR analysis. 
 
5.2.4 Preparation and Loading of Nanocapsules  
 Nanocapsules were prepared by interfacial deposition in water. Different 
copolymer/PCL ratios were employed, an example is as follow: First, the copolymer (100 
mg) and PCL (30mg) were dissolved in acetone (27 mL) at 40 °C, after complete polymer 
dissolution, Miglyol 810
® 
(50 L) and melatonin (5 mg) were added to the mixture. Then, 
the organic solution was slowly added into MilliQ
®
 water (53 mL) under constant 
magnetic stirring at room temperature for 30 min. Afterwards acetone was removed by 
rotating evaporation and the aqueous solution was concentrated under reduced pressure. 
The final volume was adjusted to 10 mL. Nanocarriers without PCL, i.e, NC1, were 
prepared under similar conditions described above. Control experiments were carried out 
preparing formulations without melatonin. 
5.2.5 Platinum-melatonin loaded nanoparticles  
 Nanocapsule and nanoemulsion formulations were diluted 50% v/v with water, and a 5-
fold excess with respect to amino group in the PDMAEMA block, of H2PtCl6 was added 
under stirring. The sample was dialyzed against pure water for two days. Reduction of 
PtCl6 ions was performed using a 5-fold excess NaBH4, respect to Pt ions, added slowly to 
the Pt-NC under stirring. Finally, the sample was dialyzed against pure water for two days 
to remove any excess of reducing agent. Samples were analyzed by TEM. 
5.2.6 Notation  
 Formulations here prepared herein are denoted as follows: NCX-MnDm-Mel represents a 
nanocapsule loaded with melatonin where X corresponds to a number, 1 or 2, depending 
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on its content of PCL. MnDm corresponds to be diblock copolymer used (M40D108 and 
M40D471). 
5.2.7 Characterization of nanoparticles  
pH. Measurements were performed for all samples using a potentiometer (Microanal B-
474). 
Particle size distribution and polydispersity.  
 Nanocapsule suspensions, NC1 or NC2, (0.02 mg/mL respect to the PMMA-b-
PDMAEMA content) were properly diluted with 1 mM NaCl. Samples were filtered using 
Nylon filter with a pore size of 0.45 µm (13-HV, Millipore) prior to the measurement, in 
order to remove dust particles that might cause interference. Their particle size 
distributions and polydispersity index (PDI) were determined by dynamic light scattering 
measurements, which were performed with an ALV DLS/SLS SP 5022F equipment with a 
He-Ne laser ( =632.8 nm). The CONTIN algorithm was used to analyze the obtained 
autocorrelation functions. The measured electric field correlation function g1(t) was 
analyzed by means of the a cumulant expansion (eq.1): 
t
Γ
t
Γ
tΓΓg
3322
101 3!2!
tq,ln +….  (eq.1) 
 The first cumulant, 1, is related to the apparent diffusion coefficient via equation (eq.2) 
q
Γ
D 2
1        (eq.2) 
2, the second cumulant, is related to the relative standard deviation. The average 
hydrodynamic radius, Rh, can be calculated using the Stokes-Einstein equation (eq.3): 
Rηπ6
Tk
D
ho
B
  (eq.3) 
where kB is the Boltzmann constant, T is the absolute temperature, and 0 is the solvent 
viscosity. Nanocapsule PDIs were determined using cumulant analysis. 
Transmission Electron Microscopy (TEM), Cryogenic TEM (Cryo-TEM) and Scanning 
Electron Microscopy (SEM).  
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 TEM micrographs were obtained using a Zeiss EM 922 transmission electron 
microscope operated at 200 kV. NC1 and NC2 suspensions were diluted 10 times in 
Millipore water (1 mg/mL respect to PMMA-b-PDMAEMA content), and a 5- L droplet 
was deposited onto a copper TEM grid (300 mesh) coated with a carbon film, without any 
further staining process. Cryogenic studies were performed by depositing a drop of the 
nanocarriers onto the copper TEM grid (600 mesh, Science Services, München, Germany) 
and removing most of the liquid with a blotting paper, leaving a thin film stretched over 
the grid holes. The grid was immersed rapidly into liquid ethane and cooled to ca 90 K by 
liquid nitrogen in a temperature-controlled freezing unit (Zeiss Cryobox, Zeiss NTS 
GmbH, Oberkochen, Germany, and then transferred via a cryotransfer holder (CT 3500, 
Gatan, München, Germany) to a Zeiss EM 922 EFTEM. Zero/loss filtered images (ΔE = 0 
eV) were taken under reduced dose conditions (100-1000 e/nm
2
). All images were 
registered digitally by a bottom-mounted CCD camera system (Ultrascan 1000, Gatan, 
München, Germany) combined and processed with a digital imaging processing system 
(Digital Micrograph 3.9 for GMS 1.4). Scanning electron microscopy (SEM) images were 
recorded using a LEO 1530 Gemini microscope, and the samples of solid powder were 
loaded on the carbon film substrate. 
Encapsulation Efficiency (EE).  
 Melatonin was assayed by high performance liquid chromatography (HPLC). 
Measurements were conducted on a thermo separation product chromatographic system 
composed of a pump P4000, an autosampler AS3000 and an UV-detector UV6000LP with 
a wavelength =229 nm was used as detector. A reversed phase column C18, 250x4.6 mm 
ID, 1000 Å pore diameters, with 7 µm average particle sizes, was employed (Macherey-
Nagel). The solvents, acetonitrile (ACN) and water (H2O), were HPLC grade and used 
freshly. The solvent composition for the measurements was ACN/H2O 55/45 (v/v) at 23°C 
with a flow rate of 0.7 mL/min. These experimental parameters are based on a previous 
study and where described elsewhere.
41
 Predetermined concentration of pure melatonin 
solutions were used to calibrate the detector and a new calibration curve were done daily. 
Free melatonin was separated from colloids by ultrafiltration–centrifugation (Ultrafree-MC 
10,000 MW, Millipore). Total drug was measured, after dissolution of colloids with 
acetonitrile. The associated melatonin with the NC1 and the NC2 was calculated from the 
difference between the total and the free drug concentrations. 
5. Vesicular Nanocarriers 104 
 
5.3. Results and Discussions 
 The nanocarriers were prepared by interfacial deposition technique using the PMMA-b-
PDMAEMA block copolymers. Melatonin which is slightly soluble in water but 
completely soluble at the concentration used in the organic solution of polymer and oil is 
expected to precipitate after the diffusion of the solvent into the aqueous medium. Here, we 
refer to so-called nanocarriers NC1 or NC2 for nanocapsules prepared with and without 
PCL, respectively. PMMA-b-PDMAEMA has a long hydrophilic PDMAEMA chain and 
when PCL was used (NC1), one expects to have a suprastructure like a nanocapsule. The 
oil core is surrounded by PCL which is anchored with PMMA-b-PDMAEMA. When no 
PCL is used, the expected suprastructure for NC2 is like a nanoemulsion stabilized by the 
copolymer, acting as an interfacial agent. So, the copolymer is located at the interface 
surrounding the oil core. The reason to use PCL is related to its ability of stabilizing 
nanoemulsions by encapsulating it and forming nanocapsules.
42,44
 The LCST behavior of 
PDMAEMA also opens up another possibility to separate and to collect the nanocarriers 
from the solution by simple filtration after heating the solution above the cloud point. 
 The particle size and shape of the nanocarriers play an important role in the efficiency 
of the drug delivery. For instance, the bioavailability, the timed/controlled release of the 
drug, the targeting of direct intracellular delivery, the clearance and opsonization processes 
are strongly related to it. Thus, the determination of this property of the colloidal carriers is 
one of the key parameters in any study.
45-47
 
 
5.3.1 Physico-Chemical Characterization  
 A first important property which needs to be assessed after the preparation of 
nanoscopic carriers is its size, size distribution and the stability of the formed dispersion. 
All formulations studied were macroscopically homogeneous and stable. Figure 1 (bottom) 
shows a representative autocorrelation function and the CONTIN analysis obtained for 
some of the formulations. Unimodal and narrow distributions were observed in each case. 
Table 2 summarizes all values obtained for the formulations under study. Hydrodynamic 
radii ranged between 100-180 nm (i.e. mean diameters between 200-360 nm) optimal for 
oral drug delivery systems, where a favorable particle size should be lower than < 500 
nm.
8,45,47,48
, The sample polydispersity listed in the same table was calculated from the 
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cumulant analysis at the scattering angle of 90°. For almost all formulations, values were 
lower than 0.13, indicating a moderate size distribution of the nanoparticles. 
  
Table 2. Physico-Chemical Characterization of nanocarriers loaded with melatonin
a
 
 Miglyol 
(µL) 
PCL 
(mg) 
MnDm 
(mg) 
Rh 
(nm) 
PDI pH 
(±0.02) 
       
NC2- M40D108-Mel-A 250 - 100 143 0.060 8.25 
NC2- M40D471-Mel-A 50 - 30 135 0.010 7.88 
       
NC1- M40D108-Mel-A 50 30 100 95 0.060 7.98 
NC1- M40D108-Mel-B 250 100 100 128 0.110 8.12 
NC1- M40D108-Mel-C 330 100 100 137 0.117 8.30 
NC1-M40D108-Mel-D
b
 250 100 100 123 0.120 8.23 
       
NC1- M40D471-Mel-A 50 30 100 115 0.125 7.90 
NC1- M40D471-Mel-B 200 30 100 161 0.042 8.14 
NC1- M40D471-Mel-C 200 100 100 134 0.009 8.52 
a) In all melatonin containing formulations the concentration of melatonin was 0.5 mg/mL 
b) melatonin concentration = 1.0 mg/mL 
MnDm: PMMA-b-PDMAEMA content (mg) 
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Figure 1. Angular dependence of decay rate
 
obtained from DLS data of diluted 
nanoparticles loaded with melatonin (CNaCl = 1 mM) (  = NC1- M40D108-Mel-A;                
○ = NC1- M40D471-Mel-A; ■= NC2- M40D471-Mel-A). 
 
 Figure 1 (top) depicts the typical linear q
2
 dependence of the decay rate, , evidencing 
the diffusive behavior of the investigated particles. Thus, the Stokes-Einstein equation can 
be applied to determine reliable hydrodynamic radii from DLS.  
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5.3.2 Morphological Study 
 The influence of the particle shape in the drug delivery has not been fully elucidated. 
But certainly, the particle shape along with the size and the chemistry are critical 
parameters in the designing of drug nanocarriers.
47
 We have investigated the shape and the 
morphology of the nanocontainers by standard- and cryo-TEM. Figure 2 shows the air-
dried TEM micrographs for the NC1 prepared with both diblock copolymers (A and B) and 
for a NC2-M40D471-A. It can be observed from the micrographs that nanocarriers show a 
well-defined structure with spherical shape. In the case of NC1, it is possible to distinguish 
a melatonin core surrounded by a thin shell of polymer, possibly PCL. In Figure 2A, this 
shell has a thickness of approximately 15 nm, and the oily core has a diameter of 154 nm. 
Particle sizes from TEM presented smaller size compared to the results obtained by DLS. 
Reductions of the size are attributed to the specificity of the measurements. With DLS a 
highly soluble and a more expanded structure is measured, the PDMAEMA block is 
solvated and extended in water, unlike the sizes obtained by standard TEM, where 
structures collapse in the dried state. In the first case, z-average particle size is determined 
while by TEM it is a number-average. 
 Since methacrylates degrade upon electron beam
49,50 
it is not possible to distinguish 
PCL and PMMA-b-PDMAEMA at the interface of the core. Nevertheless, the fact that all 
colloids were macroscopically homogeneous and no other surfactants were used (the 
copolymer is acting as surfactant), together with the basic pH values measured, seems to 
support the structure proposed in the Scheme 1, where the copolymer should be in the 
outer part of the shell with the hydrophilic PDMAEMA block interacting with the aqueous 
phase and stabilizing the nanocarriers and in the inner one the PCL and PMMA at the 
interface of the oily core, with, probably, some chain fragments solubilized inside it. In the 
TEM picture of the NC2- M40D471-Mel-A (micrograph C) the presence of the copolymer is 
not visible either and due the absence of PCL, no shell was observed. 
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Figure 2. Non-stained TEM images for (A) NC1- M40D471-Mel-A, (B) NC1- M40D108-Mel-
A, (C) NC2- M40D471-Mel-A. Cryo-TEM image of NC1-MD2-Mel-A (D); the circles 
denote the swollen PDMAEMA shell. TEM images of Pt loaded (E) NC1- M40D471-Mel-A 
and (F) NC2-M40D471 
 
 In order to prove the presence of copolymer in the outer part of the NC1, cryo-TEM was 
performed. Cryogenic TEM allows the visualization of particle shape and size in situ in 
solution rather than in a dry state since the sample is vitrified in a thin layer or water before 
the measurement. Although the shell does not present a high contrast in water, a diffuse 
shadow surrounding the oily core can be seen, which corresponds to the highly solvated 
PDMAEMA chains in the mixture PCL/M40D471. Probably PCL is collapsed and would not 
show a shadow. 
 To further confirm the location of PMMA-b-PDMAEMA, NC1-M40D471-Mel-A and 
NC2-M40D471 were loaded with platinum nanoparticles. Hexachloroplatinum acid 
specifically binds to amino functions. After the coordination of H2PtCl6, reduction by 
NaBH4 leads to the generation of Pt nanoparticles inside the corona. As depicted in 
micrographs E and F, a preferential location of the Pt nanoparticles is not observed, 
nevertheless, there is a darker and denser ring of metallic nanoparticles localized at the oil-
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polymer interface where the diblock should be. Thus, these results together with the cryo-
TEM provide convincing evidence for the proposed structural model (Scheme 1). 
 One of the advantages of employing polymers containing an amino function, like 
PDMAEMA, is that it opens up the possibility of creating a variety of nanoparticles with 
promising biomedical applications by complexation with, for instance, fluorescent 
quantum dots (CdSe, CdS), metallic nanoparticles, plasma probes (Au), resulting in an 
interesting way of functionalizing drug carriers with probes to monitor particle migration 
in the body by X-ray, computer tomography or fluorescence microscopy. The possibility of 
“decorating” the melatonin-loaded nanocarriers with metallic nanoparticles may results in 
a promising alternative to further investigate its migration and accumulation in cellular and 
in in vivo experiments. 
 
Scheme 1. Hypothetical structural model for melatonin-loaded nanocapsules 
 
 
 The information about the stability of the nanocarriers in the dry state might be useful 
for the storage of the nanocarriers in the final formulation. To investigate this, NC1-MD1-
Mel-B was frozen with liquid nitrogen and lyophilized without any additional treatment. 
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The solid sample was analyzed by SEM. The particles that remained intact have a round 
shape with a rough surface (Figure 3). 
 
Figure 3. SEM micrograph of a freeze-dried NC1- M40D108-MEL-B sample. 
5.3.3 Encapsulation Efficiency (EE)  
 After assessing the size distribution, we evaluated a second important parameter, the 
encapsulation efficiency (EE), by assaying in HPLC the free melatonin separated 
previously using ultrafiltration-ultracentrifugation. The efficiencies of melatonin 
encapsulation ranged mainly between 22.7% and 29.9% (Table 3). The lowest efficiency 
(2.7%) was observed by the nanocarrier without PCL and with longer PDMAEMA block, 
NC2- M40D471-Mel-A. In general, low encapsulation efficiencies might be attributed to the 
solubility of melatonin in water (0.1 mg/ml) or to the poor diblock ability to keep the drug 
encapsulated inside the oily core. To enhance the encapsulation, a nanocapsule with higher 
melatonin content (1 mg/ml) was prepared and evaluated. The particle size remained 
slightly unchanged by increasing melatonin concentration (NC1-M40D108-Mel-D, in Table 
2). As it can be observed in Table 3 by increasing the melatonin by a factor of 2, the 
efficiency increased to 35.5%, what represent an increase of drug loaded of 18.4%. This 
result seems to indicate that there is a limit of the capacity of the NC1, prepared under the 
experimental conditions, to load more melatonin inside the container. Since, it has been 
reported that the addition of inorganic salts to the nanocarrier formulations may induce 
changes in the drug entrapment due to the osmotic gradient between the internal and the 
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external phase,
51,52
 we therefore tried to further optimize the melatonin loading by the 
addition of a low molecular weight salt (0.01M NaCl). We observed a slight enhancement 
of the EE, with values ca. 5% higher than those without NaCl added, what means that the 
melatonin encapsulated increased by ca. 14.7% and 10.7% for NC containing 0.5 and 1.0 
mg/ml, respectively. 
TABLE 3. Melatonin Encapsulation Efficiencies 
Sample %EE 
NC1- M40D108-Mel-A  22.7 
NC1- M40D108-Mel-B 29.9 
NC1- M40D108-Mel-C 26.4 
NC1- M40D471-Mel-A 25.1 
NC1- M40D471-Mel-B 23.2 
NC1- M40D471-Mel-C 25.7 
NC2- M40D108-Mel-A 24.3 
NC2- M40D471-Mel-A 2.7 
Na-NC1- M40D108-Mel-B 34.3* 
Na-NC1- M40D108-Mel-D 39.2* 
   * samples with 10 mM NaCl added 
 
5.4. Conclusions 
 Encapsulation of melatonin was carried out by interfacial deposition using an 
amphiphilic diblock copolymer, PMMA-b-PDMAEMA, and a mixture of the linear 
diblock copolymer with PCL. This first attempt to encapsulate melatonin with a 
thermoresponsive and multifunctional diblock copolymer allowed the preparation of 
nanocarriers whose particle size and shape were extensively characterized by DLS, TEM 
and SEM. By the method employed here, nanocarriers were prepared without using low 
molecular weight surfactants as stabilizers, as commonly used in these formulations, 
proving that the amphiphilic behavior of the diblock was sufficient to stabilize the 
nanoparticles. Drug content measurements indicate that melatonin was loaded with an 
encapsulation efficiency of mainly ca. 22.7 to 29.9%, depending on the formulation, which 
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can be slightly enhanced by the addition of NaCl. We could prove that nanocarriers are 
composed by a core containing oil and melatonin, surrounded by PCL and PMMA-b-
PDMAEMA. The successful adsorption of platinum nanoparticles to the nanocarriers may 
provide a promising way to track the migration of the nanocontainers once they are 
introduced into the body. In summary, the use of a multifunctional diblock copolymer 
combines easy encapsulation, separation/purification and the ability of incorporating 
functional nanoparticles and thus presents significant advantages and an alternative to 
classical low molecular weight surfactants.  
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